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Abstract
This thesis describes the design and fabrication of a microuidic lab-on-a-chip (LOC)
device that mimics the lumenal architecture of the human gut and was used to investi-
gate a bacterial toxin as a driver of colon carcinogenesis. A lumen was created inside a
hydrogel within a PDMS LOC device using a PDMS rod to enable adherence of human
colonic HT29 cells. To enable this, the hydrophobicity / hydrophilicity of three dierent
concentration gelatin and collagen hydrogels was investigated, by measuring the contact
angle of water on the hydrogel surfaces. The morphology and metabolism of the HT29
cells was also investigated on the six dierent hydrogels. A 5% gelatin hydrogel was
selected for the formation of lumens inside the LOC devices because it was the most
hydrophilic hydrogel surface. HT29 cells formed a conuent monolayer on the hydrogel
after 72 hours of incubation. The cells also adhered inside the lumens, but did not form
a conuent 2D monolayer, possibly due to the initial seeding concentration being too
low. The LOC device provides a template from which future work could focus on the
optimisation of cell culture inside the lumen.
Due to the production of a toxin (Bacteroides fragilis toxin (BFT)), the carriage
of enterotoxigenic B. fragilis (ETBF) in the colonic mucosa of humans is associated
with an increased risk of colon carcinogenesis. BFT is a metalloprotease, which has
been associated with the cleavage of E-cadherin adherens junctions in the intercellular
space. Once cleaved, the gut epithelium becomes compromised, increasing the risk of
carcinogenesis. To investigate the role of the BFT as a driver of colon carcinogenesis.
BFT-treated HT29 cells grown on 5% gelatin hydrogels were exposed to BFT for 12 or 24
hours. These experiments were conducted on cells in uorodishes and demonstrated the
loss of E-cadherin and cell rounding after 12 and 24 hours. In future, these experiments
should be carried out on conuent cells lining the lumen of the chip, as the work carried
out in this study has provided the basis for this to be executed.
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1.1 Biological models for cell culture
1.1.1 Two-dimensional biological models
Two-dimensional (2D) cell culture models are traditionally based on the formation and
growth of cellular monolayers, which adhere to a at, horizontal, rigid surface [1, 2]. Cells
grown in monolayers can be exposed to the same, or a very similar amount of growth
factors and nutrients present in the culture media, which allows them to proliferate over
time. Because these models are simple and easy to form, they have been widely used to
investigate a variety of cellular behaviours such as dierentiation, growth, migration and
responses to dierent stimuli [3, 4, 5].
2D cell cultures have been used in cancer research to study aspects such as the regu-
lation of cell growth and response to chemotherapeutics. There are drawbacks however,
to using using 2D cell culture models. Cells grown in monolayers are generally more
susceptible to the cytotoxic eect of xenobiotics in comparison to those growing in a
3D micro-environment [6]. With chemotherapeutic drug treatments, more than 80% of
drug candidates for cancer treatment fail during the second and third phase clinical trials
[7]. 2D cell cultures also lack the micro-environmental architecture and cellular proper-
ties that solid tumours exhibit in vivo. For example, cellular behaviour and morphology
observed in 2D cell cultures may not represent those occurring in vivo [8]. To better rep-
resent the in vivo cellular micro-environment, 2D cell culture models have been modied
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with micro-wells, micro-pillars and micro-patterned substrates. These manipulations can
consequently help to better study the behaviour and morphology of cells in 2D models,
by mimicking micro-structures found in vivo [4, 9, 10].
1.1.2 Three-dimensional biological models
In view of the problems with 2D cell culture models, three-dimensional (3D) cell cul-
ture models been developed as a more clinically relevant culture method because they
can enable the creation of biologically realistic cellular environments. 3D models provide
extracellular environments which enable cells to adhere and grow both horizontally and
vertically, similar to how cells grow in vivo [1]. When cells are isolated from tissues and
cultured in 2D models, dierent cell lines have been found to become progressively atter,
exhibiting aberrant cell division and loss of their dierentiated phenotypes [1]. In con-
trast, when certain cells are cultured in a 3D environment, with appropriate extracellular
matrix (ECM) proteins, the cells are able to regain their physiological function and form
[3, 11], and in turn, cellular dierentiation, proliferation, responses and survival may be
more representative of those in vivo [1, 3, 12, 13, 14].
Various 3D cell culture methods have been used for research, such as for cancer
modelling and drug discovery, and several studies have stated that the use of scaolds
which serve as ECM substrates enable cellular adherence and growth of 3D structures
[15, 16, 17, 18]. For example, poly(n-isopropylacrylamide) (L-pNIPAM) hydrogels were
used as scaolds to investigate the development of an in vitro 3D culture model of the
human intestinal epithelium [18]. HT29-MTX cells cultured on the L-pNIPAM gels ex-
hibited the formation of villus-like structures, with positive expression of goblet cell and
enterocyte dierentiation markers. These results suggest that L-pNIPAM hydrogels have
potential to mimic the 3D structure of the intestinal epithelium, with the possibility for
studying intestinal diseases and drug ecacy [18].
Another commonly used 3D cell culture method is the formation of multi-cellular
tumour spheroids (MCTS). These can mimic the micro-environment of tissues and thus
allow researchers to investigate cancer tumour structure and behaviour [12, 13]. MCTS
have been used to investigate the drug ecacy of dierent colorectal cancer cell lines. For
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example, HT29, MCT116 and SW480 colorectal cancer cell lines have been found to have
diering sensitivity relative to each other, to the chemotherapeutic drug, 5-Fluorouracil.
The drug was also found to have a strong impact on the cohesion of cell in MCTS, in a
cell line- and 5-FU dose-dependent manner [19].
Other studies have investigated how the 3D micro-environment and extracellular ma-
trix proteins aect MCTS formation. For example, HT29 colorectal cancer cells have
been found to enhance MCTS formation on gelatin and collagen nano-scaolds, suggest-
ing that cells are more inclined to grow as multicellular spheroids and less subject to
disaggregate [13, 19]. Although 3D cell culture models such as MCTS can help to mimic
the in vivo micro-environment, cultivation is time-consuming and complicated, and it
can be dicult to generate spheroids of uniform size [19]. These drawbacks have driven
researchers to investigate the use of non-traditional 3D cell culture models, namely, mi-
crouidic devices. These platforms have gained a large interest in the areas of cellular
and molecular biology in recent years, due to the low cost and easy manipulation. Section
1.1.3 will discuss this further.
1.1.3 Microuidic devices for biological applications
Microuidics is a term used to describe the science and technology of systems which
manipulate or process small amounts of uids using channels. In recent years, mi-
crouidic devices, known as "chips" or "lab-on-a-chip" ("LOC"), have been used for
biological applications, such as for cell culture inside devices which can mimic in vivo
micro-environments. Several models have been designed for various biomedical uses and
applications; including drug screening, toxicology testing and drug targeting [20, 21, 22].
Cell culture within some LOC devices have enabled better observation of cancerous cell
growth and action [17, 20, 23], however, most of these devices have been limited in under-
standing complex tumour physiology in vivo because of the use of planar 2D monolayer
cell structures [21]. To work around such limitations, LOC devices have been designed
and fabricated to replicate the 3D structure of organs and tissues [21]. These models
have the potential to be used for the investigation of functions and mechanisms of human
tissues, as well as the study of disease pathology [21].
4
Formation of lumenal structures from hydrogels
Hydrogels have been incorporated in LOC devices to create more biologically relevant
models for cell culture. Hydrogels are highly hydrated, cross-linked, three-dimensional
networks of hydrophilic polymers [24, 25]. Depending on their chemical composition,
hydrogels can be responsive to a variety of stimuli, such as pH, light, chemicals and heat
[26, 27]. ECM proteins are often used in hydrogels to facilitate cellular encapsulation,
embedding and / or adherence in vivo [27, 28]. This helps to create cellular environments
that are more similar to those found in vivo [18, 20, 27, 29, 30].
A commonly used protein in hydrogels is type 1 collagen. The molecule has been seen
as an attractive option for hydrogel formation, likely because it is the most abundant
protein in humans and plays several roles in the extracellular matrix [31]. Type 1 colla-
gen can interact with other ECM molecules, cell surfaces and growth and dierentiation
factors, providing tensile strength to support the integrity of several tissues in the body
[31]. Gelatin is also commonly used in hydrogel formation because it is a derivative of
collagen. It forms when collagen is thermally denatured, yielding smaller peptides from
the collagen brils [30]. This molecule is generally less expensive than type 1 collagen and
other biomaterials, such as matrigel and hyaluronic acid. Gelatin therefore has potential
to be used as an alternative biomaterial in LOC devices [32, 33].
Several studies have incorporated hydrogels into LOC devices to form lumenal struc-
tures. Articial lumens have been created out of a collagen hydrogel, by placing a poly-
dimethylsiloxane (PDMS) rod inside a LOC device, followed by injection of the hydrogel
[20]. Once the gel solidied, the rod was removed, leaving a lumen inside the device.
This model has been used to form articial blood vessels using Human Umbilical Vein
Endothelial Cells (HUVEC) cells [20]. Hydrogels can also be manipulated to form various
lumenal structures inside LOC devices [20]. Recently, a 3D LOC device was fabricated
to mimic the human colorectal tumour micro-environment in vitro [22] (Figure 1.1).
HCT116 colorectal cancer cells were suspended in Matrigel and injected into the central
device chamber [22]. The device was then used to validate the ecacy of drug-loaded
nano-particles in a gradient. This suggests that LOC devices are capable of re-creating
micro-environments found in vivo and can be used to test the eectiveness of dierent
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therapeutics.
Figure 1.1: Formation of a 2D cell monolayer inside a lumenal structure to mimic the
architecture of the human gut.
1.2 Perturbance of the normal gut: A potential inu-
encer of colon carcinogenesis
1.2.1 Gut homeostasis
The human gastrointestinal (GI) tract is home to millions of individual bacteria. Host
nutrient availability, mucosal surfaces, oxygen exposure, pH, host secretions and inter-
actions with the immune system are thought to govern the formation of dense bacterial
networks, which are metabolically active [34]. The composition of the microbiota is a pri-
mary factor, which helps to determine the type and robustness of host mucosal immune
responses [35]. The Bacteroides genus comprises almost half the gastrointestinal faecal
ora of humans. Their ability to process complex molecules plays an important role in
host nutrition, as the presence of Bacteroides species has been found to enhance lipid and
carbohydrate absorption by the host [36]. Although dynamic interactions between the
host and these residing bacteria can be benecial for host health [37], it is important to
maintain intestinal homeostasis, through separation of the microbiota and immune sys-
tem, to prevent an immune response to these bacteria in the gut. Several biophysical and
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biochemical barriers exist, including the production of antimicrobial compounds, mucus
and production of tight junctions between epithelial cells [38].
1.2.2 Cell-cell adhesion
To maintain barrier function, normal cellular architecture and morphology, endothelial
and epithelial cells form intercellular adhesions through the homophilic and heterophilic
interactions of cell adhesion molecules (CAMs) [39, 40]. These adhesions are crucial for
the well being of multicellular organisms, because they maintain stability during tissue re-
generation, wound repair and physical movement [39, 41, 42]. The cadherin super family
proteins are cell surface glycoproteins that are responsible for calcium (Ca2+) dependent
homophilic cell-cell adhesions [42]. Four groups of cadherins exist, these are classical
cadherins (further sub-divided into Type-I and Type-II), desmosomal cadherins, proto-
cadherins and unconventional cadherins. All cadherins contain extracellular calcium-
binding (EC) repeats, which vary in number depending on the specic type of cadherin
[42, 43]. Classical cadherins have a similar structure and topology, with ve EC repeats
and an intracellular and transmembrane domain. Type-I cadherins, including neuronal
(N) and epithelial (E) cadherin, have a conserved EC1 domain with ve repeats (Figure
1.2). These mediate homophilic adhesions between cells and play important roles in the
GI-tract, as described in Section 1.2.3 [42, 44, 45].
1.2.3 Role of E-cadherin in the gastrointestinal tract
E-cadherin is a 120kDa Type-I classical cadherin encoded by the CDH1 gene in humans
(Figure 1.2). The cytoplasmic domain is bound to β-catenin, which interacts with α-
catenin and actin microlaments, as shown in Figure 1.2 [46, 47]. E-cadherin enables
epithelial monolayers to act as protective barriers against extracellular pathogens and
chemicals in the GI-tract [46, 48]. Loss of E-cadherin through CDH1 mutation, or by
physical cleavage, can compromise the intestinal epithelial barrier, leading to inam-
mation, tissue thickening and scarring [49]. These symptoms are commonly observed
in colorectal cancer (CRC) formation, contributing to the development of polyps and
tumours in epithelial sheets [44, 48, 49, 50].
7
Figure 1.2: An E-cadherin cell junction between two epithelial cells, showing the con-
served EC1 domains in the intercellular space, and the binding of the intracellular
domain to β-catenin.
1.2.4 Colorectal cancer
CRC is the second most commonly diagnosed cancer in New Zealand, and its prevalence
is increasing due to change of the population demographic over time [51, 52]. A small
fraction of CRC cases arise due to genetic pre-disposition [53]; however, more than 85%
of CRC cases are considered to be sporadic. The development of CRC is a multi-step
process, by which tumour suppressor genes such as p53 are inactivated, and oncogenes
such as mutated adenomatous polyposis coli (APC ), are activated, as described in Figure
1.3. Research has suggested that there are several risk factors for CRC formation, with
recent studies proposing a role of human lifestyle, including diet, as potential drivers
of DNA damage [54, 55, 56, 57]. Over time, damage can lead to mutations, chronic
inammation and formation of pre-cancerous tumours [58].
Figure 1.3: The adenoma-carcinoma process, by which cells in a normal epithelium
undergo several genetic mutations, leading to cancer formation.
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1.2.5 Microuidics to model carcinogenic changes in vitro
2D cell culture methods and animal models have been used to study cancer formation,
progression and therapeutics. These models however, may not accurately represent the
tumour physiology and micro-environment in the human body [22]. Consequently, more
than 80% of drug therapy candidates have anti-cancer drugs fail during the second and
third phase of clinical trials [7]. Because of this, in recent years there has been an
increased demand for cell culture methods which enable researchers to study cancer cells
in a more biologically realistic environment. As a result, biomimetic LOC devices have
been developed in an attempt to represent the micro-environments present in the human
body [7, 20, 22]. LOC devices have been fabricated that contain lumenal structures, which
can be used to represent the architecture of blood vessels and the GI-tract [20, 21]. These
devices can therefore provide researchers with more biologically relevant platforms that
have the potential to better represent and understand the complexity of carcinogenesis
in vivo [59].
1.3 Bacterial drivers of carcinogenesis
1.3.1 Toxigenic bacteria can modulate homeostasis
Numerous studies suggest a role for the intestinal microbiota in the pathogenesis of sev-
eral inammatory diseases, such as irritable bowel disease, ulcerative colitis and CRC
[60, 61, 50]. Toxins produced by bacterial strains, such as enterotoxigenic Escherichia
coli, are thought to compromise the intestinal barrier, aect the host immune system and
disturb homeostasis in the gut [62]. When homeostasis is compromised, susceptibility to
intestinal inammation and disease can increase [34, 63, 64, 65].
Bacteroides fragilis resides in the guts of most humans. It is usually passed from
mother to child during birth, and colonisation by the bacterium usually promotes mu-
cosal health in the GI-tract [66, 67]. Although colonisation by B. fragilis usually has a
positive eect on its host, some strains are known to be enterotoxigenic. These strains
have thus been grouped into a subset of the bacterial species for classication purposes.
Enterotoxigenic B. fragilis (ETBF) produce a protein, termed Bacteroides fragilis toxin
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(BFT), which is a 20-kDa extracellular zinc metalloprotease with three known distinct
subtypes [68, 69]. It acts as a toxin in the human gut by cleaving E-cadherin cell junc-
tions, activating immune responses that are dependent on T-cells, and compromising the
GI epithelium [70, 71]. Consequently, the ETBF subset has been associated with the
formation of gut-centred diseases and may play a role in colon carcinogenesis [50, 60, 61].
1.3.2 Role of ETBF in colon carcinogenesis
BFT has been found to reversibly stimulate the secretion of chloride ions and alter the
function of cellular tight junctions in polarised epithelial cells of the intestine, as shown
in Figure 1.4 [72]. It does not appear to directly cleave E-cadherins, but rather, binds to
a specic colonic epithelial cell (CEC) receptor on the epithelial surface (Figure 1.4) [66].
This is thought to trigger the disassembly of adherens junctions and degradation of the
E-cadherin proteins [46, 66, 73]. BFT is also able to modulate intracellular signalling of
the Wnt signalling pathway. When E-cadherin is cleaved, nuclear signalling by β-catenin
is increased, triggering cellular proliferation in the colon (Figure 1.4) [66, 72, 74, 75].
Figure 1.4: BFT binds to an uncharacterized CEC receptor on the cell surface, trig-
gering intracellular signal transduction, cleavage of E-cadherin, up-regulated Wnt
signalling and secretion of inammatory molecules. These aspects contribute to ETBF-
mediated DNA damage, increased intestinal barrier permeability and increased risk of CRC
formation.
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Carriage of ETBF is common in people with CRC and is linked to an increased risk of
low-grade colonic dysplasia. The bft gene has also been found to be over-represented in
mucosal biopsies and stool samples obtained from patients with CRC [76, 77, 78]. BFT
expression has also been shown to induce prolonged colitis in mice, through the disruption
of E-cadherin junctions, activation of β-catenin signalling, and secretion of inammatory
molecules such as interleukin-8 (IL-8) [46, 72].
In one clinical study investigating mucosal colonisation by ETBF and its impact on
colon carcinogenesis, bacterial colonies were isolated from samples obtained from patients
with colorectal neoplasia and from patients undergoing colonoscopies for CRC screening
[71]. Polymerase chain reaction (PCR) was used to test for the presence of the bft gene
[71]. A trend toward increased BFT positivity in the mucosa from early- versus late-stage
CRC patients showed that the bft gene was associated with colorectal neoplasia, espe-
cially in cases of late-stage CRC [71]. Data also suggested that exposure of the intestinal
mucosa to BFT is common in patients with CRC, suggesting that toxin exposure is a risk
factor for CRC development [71]. This study supports prior research which found that
detection of BFT in human stool samples was signicantly higher in hospitalised CRC
patients than in samples obtained from outpatient controls [76].
In another clinical study investigating the presence and relative abundance of the bft
gene in mucosal tissue, samples from four dierent colonic sites were obtained from 150
patients referred for colonoscopies in New Zealand [73]. ETBF was present in all colonic
sites, with an increase in ETBF positivity and abundance on the left site of the GI-tract,
including the descending colon and rectum [73]. This is consistent with previous literature
which reported ETBF colonisation throughout the entire gut [71, 77]. The increased
abundance and positivity of ETBF was associated with early stage carcinogenic lesions
in the patients tested, suggesting that ETBF has potential to be used as a marker of
early stage colon carcinogenesis [73].
1.3.3 HT29 cell line to investigate colon carcinogenesis
In addition to the clinical studies described in Section 1.3.2, the eect of BFT on cultured
cancer cell lines has also been investigated. The HT29 cell line was originally isolated
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from a primary colorectal tumour of a 44 year old Caucasian woman [79]. The cells
are able to form conuent monolayers, as shown in Figure 1.5, and are characterised by
E-cadherin, denoting the formation of adherens junctions between adjoining cells. HT29
cells also have high sensitivity to BFT, which caused cleavage of E-cadherin [80, 81, 50].
The E-cadherin ecto-domain was released and the intracellular fragment was processed
via γ-secretase activity, resulting in cell rounding. Evidence has shown that HT29 cells
treated with 100 ng /mL (5 nM) of BFT stimulated cell rounding and loss of adherens
junctions, in 100% of cells after 45 minutes [72].
Figure 1.5: Conuent HT29 colorectal cancer cells growing on polystyrene plastic
after 72 hours of incubation at 37◦C and 5% CO2.
1.3.4 Project aims and objectives
The purpose of this project was to provide a new model, which could potentially be used
to investigate colon carcinogenesis and to show that BFT is a potential driver. Several
studies have suggested an association between intestinal carriage of ETBF and increased
risk of colon carcinogenesis, through the cleavage mechanism of BFT [36, 66, 71, 72].
Highly specic cleavage of E-cadherin cell junctions by BFT has been demonstrated
using 2D cell culture models [72]. These models however, have been unlikely to replicate
the complex gut micro-environment and architecture in vivo. As such, the rst objective
for this project was to fabricate a lab-on-a-chip device, which mimicked the lumenal
architecture of the human gut. The second objective was for HT29 cells to adhere and
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grow as a 2D monolayer inside the lumenal walls of the LOC device (Figure 1.1). The last
objective of this study was to show that BFT was linked to the cleavage of E-cadherin,
which could be detected by a morphological change. In turn, this would suggest that
the LOC device could be used as a more biologically relevant model for investigating the
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Table 2.3: Antibodies and Cell Stains
Antibody or Cell Stain Source
Anti-E-Cadherin antibody [M168] -
C-terminal (ab76055), product size =
100µL.
Abcam, AU.
Goat Anti-Mouse IgG H&L (Alexa












One PBS tablet (Thermo Fisher Scientic, NZ)
dissolved in 100mL DI water, autoclaved.
McCoy's Media. McCoy's (Modied) 5A Media with L-glutamine and
phenol red (Thermo Fisher Scientic, NZ),
supplemented with 10% heat-inactivated fetal bovine
serum (Thermo Fisher Scientic, NZ) and 1mL of
penicillin-streptomycin per 100mL of media
(10,000U/mL) (Thermo Fisher Scientic, NZ).
Freezing Media. 900µL of McCoy's Media and 100µL of 10%
Dimethyl Sulfoxide (DMSO) (Thermo Fisher
Scientic, NZ).
Gelatin Hydrogel. Gelatin from porcine skin Type A (Sigma-Aldrich,
NZ) dissolved in 1 x PBS. Cross-linked by
transglutaminase enzyme (100U/ g, Anjinomoto,
JP) dissolved in 1 x PBS.
Collagen Hydrogel. Rat tail collagen type 1 (9.04mg /mL)(InVitro NZ
Life Science), 1x PBS and NaOH (0.5M)
(Sigma-Aldrich, NZ).
1% Formaldehyde. 1mL Formaldehyde solution (37 wt. % in H2O,

















Chrome etchant solution ceric ammonium nitrate : perchloric acid :H2O =
10.9% : 4.25% : 84.85% (Sigma-Aldrich, NZ).
Table 2.5: Consumables
Consumable Name Source
Greiner 50mL 25 cm cell culture ask with lter cap. Lab Supply Ltd, NZ.




Costar 24-Well Cell Culture Plates. Corning Life Sciences,
USA.
Costar 6-Well Cell Culture Plates. Corning Life Sciences,
USA.
Terumo Syringe, Leur Lock (5mL, 100 units). MediRay, NZ.
Gelatin from porcine skin (1Kg). Sigma-Aldrich, NZ.
Axygen 1.7mL MaxyClear Snaplock Microcentrifuge




Axygen 0.6mL MaxyClear Snaplock Microcentrifuge
Tubes (Polypropylene, Clear, Nonsterile).
Corning Life Sciences,
USA.
Nunc OmniTray Single-Well Plate (OmniTray Cell
Culture Treated, with Lid, Sterile, PS).
Thermo Fisher Scientic,
NZ.
Falcon Collagen I (rat tail, 100mg). InVitro NZ Life Science.
Tefzel (ETFE) tubing (1 / 16" OD x .040" ID,
1517XL Tub Tfzl Nat 1 / 16 x.040 x 100 ft)
IDEX Health and Science,
USA.




Negative-tone dry lm resist (SUEX300). DJ MicroLaminates, USA.
4-inch silicon wafers (prime grade single-side polish). WaferPro, USA.
Polydimethylsyloxane (PDMS Sylgard 184 silicone
elastomer kit).
Electropar, NZ.
TE Series 14-gauge needle (1 / 2", 50 pack). Techcon, USA.
Terumo blunt 18-gauge needle (1.5", 1.2 x 38mm,
100 pack).
McFarlane, AU.




TE series 21-gauge needle (1 / 2", 50 pack). Techcon, USA.
Tubing tygon (1.6 x 32mm, 50 ft). Thermo Fisher Scientic,
NZ.
P-733 PEEK shut-o valve. IDEX Health and Science,
USA.
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1 / 4-28 angless tting nut, Short (XP-218 x
Flangeless Fitting for 1 / 16 OD Tubing  10 pack).
IDEX Health and Science,
USA.
XP-200 x angless blue ferrules (Standard 1 / 16 10
pack).
IDEX Health and Science,
USA.
P-671 PTFE threaded adapter (0.040 thru-hole). IDEX Health and Science,
USA.
Microuidic Fittings (1 / 4"-28 Kit to 1 / 16" OD &
3/ 32" ID).





3.1 Lab-on-a-chip (LOC) fabrication
3.1.1 Mask writing and development
The computer program L-edit (Version 8.03) was used to create three separate designs
for the lab-on-a-chip, based on the design by Beebe et al., (2016) [20]. Each of these
were etched into three separate glass photomasks (masks). Each le was saved as a .dxf
le and a laser mask writer (Heidelberg µPG101 mask writer) was used to transfer each
design onto three separate masks. The masks came pre-coated with a layer of chrome
and a layer of AZ1518 photo-resist. Lithography was carried out in a yellow-lit room to
prevent alterations of the features by UV light. The masks were individually loaded into
the mask writer, and once aligned correctly, a laser was used to selectively expose the
photo-resists to UV light, transferring the uploaded designs onto the masks. Two of the
designs were combined and used to produce a wafer that comprised of two layers, forming
the base layer of the LOC, as shown in Figures 3.1 and 3.2. The third design was used to
create a wafer with a single layer, forming the top layer of the LOC, as shown in Figure 3.3.
Once all three masks were written, they were individually placed in a petri dish
containing AZ326-MIF photo developer (MicroChemicals GmbH, DE) for one minute.
Following this, the masks were rinsed with DI water and dried with a nitrogen gun; thus
removing photo-resist in the areas of the masks which were exposed to UV light. Lastly,
each design was observed using a light microscope (Nikon Eclipse Ts2) at 4 x magnica-
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tion (NA 0.10) to make sure the patterns were fully developed. Full development was
characterised by the sharpness of the edges of the etched patterns, as shown in Figure 3.4.
To etch the features out of the chrome layers on each of the three masks, chrome
etching was carried out. The developed masks were placed one at a time in a tray in
an acid fume-hood. Masks were immersed in chrome etchant solution (ceric ammonium
nitrate : perchloric acid :H2O = 10.9% : 4.25% : 84.85%) (Sigma-Aldrich, NZ) and were
gently shaken for one minute. Etchant was poured back into the bottle and the masks
were washed with DI water and dried with an air gun. Masks were checked under a
microscope at 4 x magnication (NA 0.10) to make sure all features had been etched out.
Lastly, the masks were washed with acetone, methanol and isopropyl alcohol to strip the
remaining photo-resist layers (Fig. 3.4).
Figure 3.1: Design of the rst layer which was used to form half of the base of each
LOC device. The design was physically raised so that a negative imprint would be
obtained when moulding the actual devices.
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Figure 3.2: Design of the second layer which was used to form the second half of
the base of each LOC device. The design was physically raised so that a negative
imprint would be obtained when moulding the actual devices.
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Figure 3.3: Design of the top layer which was used to form the top part of each
LOC device. The design was physically raised so that a negative imprint would be
obtained when moulding the actual devices.
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Figure 3.4: A fully developed photo mask after chrome etching.
3.1.2 Wafer lamination
A 4-inch silicon wafer (prime grade single-side polish, WaferPro, USA) was removed from
a 180◦C oven and cooled to room temperature. The wafer was placed in a plasma asher
in preparation for plasma cleaning (PIE Scientic Tergeo plasma asher). The pulse ratio
was set to 50, oxygen was 5 sccm, power was 100W and ashing time was one minute.
Meanwhile, the photoresist laminator (Sky-335R6) was set to a measured temperature of
65◦C. Once the temperature had stabilised, the rollers were switched on. An aluminium
sheet with a dened wafer holder was cleaned using methanol. Double-sided tape was
attached just above the holder and two transparent polyethylene (PE) sheets were placed
on the aluminium sheet, axing one to the tape. The wafer was placed into the wafer
holder by aligning the at edge of the wafer with the holder, as seen in Figure 3.5. The
lower PE sheet was moved so that it was approximately 10mm below the at edge of
the wafer. A negative-tone dry lm resist (SUEX300, DJ MicroLaminates, USA) with a
thickness of 300µm was selected for lamination.
The protective layer of the resist was peeled away to reveal 10mm of the dry lm. The
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dry lm was aligned to the at edge of the wafer and was gently pressed onto the wafer.
Once in place, the protective layer was fully peeled away, allowing the lm to rest on the
lower PE sheet. The aluminium sheet was placed at the edge of the rollers and carefully
fed through the laminator. As the sheet moved in, the lower PE was pulled back so that
the dry lm came in full contact with the wafer over time. Lastly, the laminated wafer
was baked on a hotplate at 65◦C for 15 minutes and the lm was peeled o the top side
of the wafer.
Figure 3.5: Placement of a wafer in the designated slot of the aluminium sheet.
3.1.3 Mask alignment
To align the etched masks and laminated wafers for the transfer of the design to the
wafers, a mask aligner ( Karl Suss MA-6) was used. The mask aligner was switched on
and the light source was left to stabilise for 30 minutes. After this, the UV exposure
intensity of the light was measured using a UV intensity meter (Suss microtech UV,
model 100 with the p365nm sensor). The measured intensity value was 2.6mW/cm 2.
Because the dry lm thickness on the wafer was 300µm, the ltered dose (mJ / cm 2 at
365 nm) was set to 1750mJ / cm 2 based on the SUEX Epoxy thin lm preliminary data
sheet (DJ MicroLaminates). To calculate the total time of exposure, the ltered dose was
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divided by the measured UV intensity, obtaining a total exposure time of 673 seconds.
To minimise thermal stress in the resist, the mask aligner was set to carry out 45 rounds
of 15 second exposures, with a one minute rest between each exposure round. The mask
with the pattern for the rst layer of the base of the LOC device was placed mirror side
down on the mask holder. The mask holder was then slotted into the mask aligner slot.
Transparent sheets were placed around the mask and the ZJB360 glass lter slide was
placed on top (Fig. 3.6). The wafer was placed in the wafer holder in the open drawer
(Fig. 3.7). Suction was turned on to prevent the wafer from moving, then the drawer
was shut. The mask aligner was run at a ltered dose of 1750mJ / cm 2 for 45 rounds of
15 second exposures.
Once the exposure process had nished, the wafer was removed and baked using a
hotplate (Torrey). The ramp setting in the hotplate was used, which meant that the
hotplate would cool down by the stated temperature every hour, until it had reached the
nal desired temperature. The rst bake was at 65◦C for 5 minutes, (ramp 100◦C/hr),
then at 95◦C for 20 minutes (ramp 100◦C/hr) and lastly at 20◦C for 20 minutes (ramp
15◦C/hr). Once baked, the wafer was laminated again using a new SUEX 300µm dry
lm (Section 3.1.2), and placed on a hotplate at 65◦C for 15 minutes. The baked wafer
was then placed in the mask aligner drawer. The second mask for the base of the LOC
device was placed on the mask holder, then inserted into the mask aligner. The ltered
dose for the second layer exposure (mJ / cm 2 at 365 nm) was 3500mJ / cm 2 because the
lm thickness had doubled since the rst exposure. To calculate the total time of expo-
sure, the ltered dose was divided by the measured UV intensity, thus obtaining a total
exposure time of 1346 seconds. The aligner again was used to carry out rounds of 15
second exposures, with a one minute rest between each exposure round to reduce thermal
stress. Once the existing rst layer resist features had been aligned with the new mask,
the mask aligner was run at a ltered dose of 3500mJ / cm 2 for 90 rounds of 15 second
exposures.
Once exposure had nished, the wafer was placed in a mesh holder in a 5-inch Petri
dish with the feature side down, as shown in Figure 3.8. PGMEA photo-developer (Sigma-
Aldrich, NZ) was poured over the wafer and it was left for one hour to develop both
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layers simultaneously. The wafer was then washed with isopropyl alcohol and dried using
a nitrogen gun. A nal hard-bake was carried out on a hotplate at the following tem-
peratures : 125◦C for one hour (ramp 100◦C/hr) and then 20◦C for 20 minutes (ramp
15◦C/hr), which completed the rst mould. The lamination process was repeated on a
second wafer to form the second mould (Section 3.1.2). For this, the third photomask
with the pattern for the top layer of the LOC device was used, as described above. After
photo-development and baking, the mould for the top layer of the LOC device was n-
ished.
Figure 3.6: Placement of the mask holder in the mask aligner, followed by placement
of the transparent sheets and glass lter slide.
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Figure 3.7: Placement of a 4-inch silicon wafer on the mask aligner wafer holder of a
Suss microtech mask aligner.
Figure 3.8: A wafer placed face-down in a mesh holder in a 5-inch petri dish, ready
for PGMEA photo-developer to be poured over it. Feature-side down developement
aided the removal of un-exposed photoresist.
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3.1.4 Soft lithography
The developed wafer was pre-treated with vapour of trichloro(1H,1H,2H,2H-peruorooctyl)
silane (Sigma-Aldrich, NZ) in a vacuum desiccator. The silane was used as it forms a thin
layer on the wafer, allowing easy detachment of PDMS from the photo-resist. A single
drop of silane was transferred into a small open bottle, which was then placed in the des-
iccator, along with the silicon wafer, photo-resist side up. A vacuum pump was applied
for 30 minutes to aid silane evaporation. Next, a polydimethylsyloxane (PDMS Sylgard
184 silicone elastomer kit, Electropar, NZ) was used for moulding. PDMS pre-polymer
and its curing agent were mixed in a plastic container at a 10 : 1 (w /w) ratio and the
mixture was degassed in a vacuum desiccator for one hour to remove air bubbles.
A clean PE sheet was placed on a square shaped at piece of metal. The wafer was
then placed on top, followed by placement of a plastic ring with a diameter 0.5 cm smaller
than that of the wafer. Use of a ring smaller than the wafer helped to restrict PDMS to
the inside of the ring. Liquid PDMS was poured into the ring onto the wafer, covering
the features (Fig. 3.9a). A second PE sheet was placed on top of the ring, as well as a
heavy metal lid to prevent leakage of the PDMS in-between the ring and the wafer (Fig.
3.9b). The set-up was placed in a desiccator for one hour to remove any air bubbles
formed during casting, and was then placed on a hotplate at 80◦C for two hours to cure
the PDMS. Once cured, the PDMS was removed from the ring using a scalpel and was
gently peeled o the wafer. It was then placed between two PE sheets and baked for
another two hours at 80◦C to complete cross-linking. This process was carried out for
both wafers each time new LOC devices needed to be made. The devices were then cut
using a craft guillotine.
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(a) (b)
Figure 3.9: Liquid PDMS moulding using the patterned wafer. (a) Placement of a
plastic ring on the wafer to prevent liquid PDMS from leaking out between the ring and the
wafer. (b) The at metal plate containing the wafer and ring placed under a weight in the base
of a desiccator.
3.1.5 PDMS rod fabrication
To form straight rods for use inside the LOC devices, an 18-gauge at ended needle was
inserted into excess PDMS, as shown in Figure 3.10a. Once removed from the PDMS, a
pair of tweezers was used to pull the rod out from inside the needle, as shown in Figure
3.10b. Rods were cut to size to t across the base layer of the LOC devices.
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(a) (b)
Figure 3.10: Formation of PDMS rods for use in LOC devices. (a) Insertion of an 18-
gauge at-ended needle into cast PDMS. (b) Removal of the PDMS rod from the needle using
a pair of tweezers.
3.1.6 Plasma bonding of LOC
To prepare the LOC devices for plasma bonding, 1mm and 2mm hole punches were used
to create holes either side of each main LOC body, as shown in Figure 3.11. The 1mm
holes were punched vertically and the 2mm holes were punched at a 45 degree angle to
facilitate rod removal. To bond the top and bases of the LOC devices together, they were
placed on a piece of PE sheet and put in the plasma asher. The pulse ratio was set to 50,
oxygen was set to mixed gas at 7,3 sccm, power was 15W and the ashing time was one
minute. Once treated, the PDMS rods were placed on the base layers, as seen in Figure
3.11, followed by placement of the top layers on the base layers. The inner rods did not
bond to the rest of the LOC because they had not been plasma treated prior to LOC
bonding. This meant that the surface energy of the base and top of the LOC devices
were not the same as the surface energy of the rods, allowing rod removal after bonding.
The at end of a pair of tweezers was then used to press the layers together, ensuring
even bonding. The LOC devices were baked on a hotplate at 80◦C for two hours to aid
bonding.
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Figure 3.11: Holes were punched in the top layer of a LOC device using 1.5mm and
1mm hole punches. A rod was placed on the base layer, then the top layer was
pressed on top, forming a LOC device.
3.2 Hydrogel formation
3.2.1 Collagen hydrogel formation
To investigate the formation of collagen hydrogels for potential use in the LOC devices,
3%, 5% and 7% concentration collagen hydrogels were made on ice by mixing 80µL of
collagen (10mg /mL) (In Vitro Technologies, NZ) and 3µL of 0.5M NaOH in 0.6mL
Eppendorf tubes. PBS was then added to each solution to adjust the concentrations.
Following this, 40µL of each collagen solution was pipetted into the bottom of nine wells
of a 96-well plate (Nunc, ThermoFisher, NZ). The plate was left at room temperature
for ten minutes, followed by incubation at 37◦C and 5% CO2 for ten minutes to solidify
the gels.
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3.2.2 Gelatin hydrogel formation
To investigate the formation of gelatin hydrogels for potential use in the LOC devices,
1%, 2%, 3%, 4%, 5% and 10% concentration gelatin hydrogels were formed. Firstly, the
required amount of gelatin powder was added to 100mL of PBS. The solutions were then
heated on a hotplate at 65◦C until the gelatin had dissolved. Following this, 0.1 g of
transglutaminase (TG) enzyme (100U/ g) (Anjinomoto, JP) was dissolved in 1mL of
PBS and added to the 1% gelatin solution. Next, 0.2 g, 0.3 g, 0.4 g and 0.5 g of TG were
dissolved in 2.5mL of PBS and added to their respective gelatin solutions. Lastly, 1 g of
TG enzyme was dissolved in 10mL of PBS and was added to the 10% gelatin solution.
Once mixed, 4mL of solution from the three containers was transferred to all wells of
three PS 6-well culture plates (Fig. 3.12). The plates were placed in an incubator at 37◦C
for 5 hours and then cooled down to 4◦C in a fridge. 1mL of PBS was then pipetted
onto each well to coat the gels. Plates were heated on a hotplate for 30 minutes at 65◦C
to heat-inactivate the remaining enzyme [82]. Excess PBS was removed from the wells
using a Pasteur pipette. Hydrogels were then observed to determine which concentrations
formed solid hydrogels suitable for cell culture, as shown in Figure 3.12.
Figure 3.12: Set 3% concentration gelatin hydrogels in a 6-well cell culture plate after
baking, cooling and heat-treatment.
33
3.3 Formation of lumens inside LOC devices
To form lumens inside the bonded LOC devices, the devices were placed in a single-welled
omnitray (Nunc, ThermoFisher, NZ) and desiccated for one hour to remove oxygen from
the PDMS. Meanwhile, 10mL of 5% gelatin hydrogel was made according to Section 3.2.2.
The space inside the LOC devices around the rods were lled with 0.1mL of hydrogel
by inserting a 21-gauge at-headed needle attached to a 1mL syringe through one of the
1mm holes in the top LOC layer. Next, 2mL of phosphate buer solution (PBS, Gibco)
was pipetted into the omnintray around the LOC devices using a 1mL pasteur pipette
to prevent evaporation of the hydrogels while baking. The devices were incubated for 5
hours at 37◦C, and were then cooled at 4◦C overnight. A pair of tweezers was used to
gently pull the rods out of the devices through the 2mm holes to form individual lumens
within the gels inside the devices, as shown in Figures 3.13 and 3.14. The LOC devices
were then sterilised under UV light in a laminar ow cabinet for one hour.
Figure 3.13: Top view of a lumen formed in a 5% gelatin hydrogel within the LOC.
The removed PDMS rod can be seen to the right of the LOC device.
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Figure 3.14: Cross-section of a lumen running horizontally through a 5% gelatin
hydrogel within a LOC, as circled in yellow.
3.4 HT29 cell culture and counting
The HT29 colonic epithelial cell line (ATCC HTB-38) was used to model the human
colorectal epithelium in vitro. Cells were grown in McCoy's 5A Medium (Gibco, NZ) sup-
plemented with 10% Fetal Bovine Serum (FBS) (Gibco) and 1% Penicillin / Streptomycin
(Gibco) at 37◦C and 5% CO2. For maintenance, the cells were grown in 25mL Greiner
asks (Lab Supply, NZ), with the media replaced every two to three days. To lift the cells,
the media was rst removed and the cells were washed with 10mL PBS (Gibco) before
the addition of 1mL of TrypLE Express (Gibco). The ask was incubated at 37◦C and
5% CO2 for ten minutes (to enable the trypsin to lift the adherent cells from the base of
the ask). Media (9ml) was added to the ask to neutralise the TrypLE. To subculture
the cells, 1mL of this cell suspension was transferred to a new ask containing 9mL of
McCoy's media.
To count the cells, 15µL of cell suspension and was mixed with 15µL of Trpyan blue
dye (0.5% w/v) (Sigma-Aldrich, NZ) to give a 1 : 1 dilution. An aliquot was placed on
a haemocytometer and cells were counted in each of the four outer corners using a light
microscope (Nikon Eclipse Ts2). These counts were averaged, then multiplied by two (to
account for the dilution in trypan blue) and multiplied by 104 to give the number of cells
per mL in the suspension.
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3.5 HT29 cell growth on polystyrene, PDMS and gelatin
thin lms
PDMS was prepared at a 10 : 1 ratio, by mixing 35 g of PDMS with 3.5 g of PDMS curing
agent in a plastic cup, which was then placed in a vacuum desiccator for 30 minutes
to remove air bubbles. A 1mL syringe was used to add 0.4mL volumes of PDMS to
wells of a 24-well polystyrene (PS) well plate (Fig. 3.15 and 3.15). The plates were
placed in a vacuum desiccator for 30 minutes, followed by a four hour hard bake on a
hot plate at 80◦C. To prepare gelatin thin lms, 0.23 g of gelatin powder from porcine
skin (Sigma-Aldrich, Auckland, NZ) was mixed with 200mL of PBS and heated at 60◦C
until the gelatin had dissolved. One mL volumes of gelatin were used to coat untreated
(polystyrene) wells, as well as wells that were already coated with PDMS. Both plates
were sterilised under UV light in a laminar ow cabinet for one hour. Excess gelatin was
removed from the coated plate using a Pasteur pipette, leaving a thin lm coating the
wells. Plates were sealed with paralm to maintain sterility until use.
Cells were counted, as described in Section 3.4 and diluted using McCoy's media to a
concentration of 5 x 10 4 per mL. Each experimental replicate consisted of seeding 1mL of
cell suspension in each of three PDMS coated wells and three non-coated PS wells in the
rst plate (Rows A and B, Columns 1, 2 and 3) (Fig. 3.15). In the second plate, the same
volume of cell suspension was added to three wells coated with both PDMS and gelatin,
and three gelatin thin coated wells (Rows A and B, Columns 1, 2 and 3) (Fig. 3.16).
Both plates were incubated at 37◦C for 24, 48 and 72 hours at 5% CO2. The supernatant
in one of the three wells was collected after 24, 48 and 72 hours incubation respectively
and non-adherent cells were pelleted by centrifugation (three minutes at 1000 rpm). The
supernatant was removed and the cell pellet was re-suspended in 100µL of media before
being counted (Section 3.4).
To collect the adherent cells in the corresponding wells, PBS was used to wash the
cells before the addition of 500µL of TrypLE express. Following a ten minute incubation
at 37◦C, 500µL of McCoy's media was added to neutralise the trypsin before the cells
were transferred to an Eppendorf tube for counting. This process was carried out twice
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more (on dierent days) in the remaining wells to a total of three experimental replicates.
To investigate HT29 cellular morphology, images were taken prior to trypsinisation on the
polystyrene, PDMS and gelatin-coated surfaces using a light microscope (Magnication
10 x, NA 0.25) (Nikon Eclipse Ts2) after 72 hours of incubation. To identify whether
trypsinisation had lifted all of the cells from the gelatin-coated surfaces, images were also
taken after trypsinisation.
Figure 3.15: 12 wells of a PS 24-well plate were coated with PDMS and the remaining
wells were left uncoated.
Figure 3.16: All 24 wells of a PS 24-well plate were coated with PDMS, and 12 wells
were then also coated with gelatin thin lms.
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3.6 HT29 cell growth on gelatin hydrogels
To measure HT29 cell growth on gelatin hydrogels at 24, 48 and 72 hours, 3%, 5% and
10% gelatin hydrogels were prepared in three PS 24-well plates, as described in Section
3.2.2. Cells were then seeded at 5 x10 4 per mL, as shown in Figure 3.17. The plates were
placed in an incubator at 37◦C and 5% CO2 for 24 hours. Images were taken using a
light microscope (Magnication 10 x, NA 0.25) (Nikon Eclipse Ts2). The supernatant was
removed and cells were collected according to Section 3.5. Adherent cells were trypsinised
using TrpyLE. Non-adherent and adherent cells were then counted according to Section
3.4. This process was repeated at 48 and 72 hours of incubation.
3.7 HT29 cell metabolism on collagen and gelatin hy-
drogels
To identify how metabolically active HT29 cells were on collagen and gelatin hydrogels,
the alamarBlue cell viability reagent was used. The active ingredient, resozurin (blue in
colour), is converted to highly uorescent resorun (red in colour) by the redox power of
living cells. The uorescence can then be measured and is proportional to the number of
living cells respiring in a sample. The aim of this experiment in this study was to identify
whether there was a signicant eect of hydrogel type and concentration on HT29 cell
metabolic activity over a 72 hour time period.
To prepare collagen hydrogels for cell seeding and the alamarBlue assay, 3%, 5% and
7% collagen hydrogels were made up according to Section 3.2.1. The collagen recipe ratio
was increased to a total of 480µL of collagen solution per gel concentration. 40µL of
each collagen gel solution was transferred to 12 wells of a 96-well plate and incubated at
37◦C and 5% CO2 (Section 3.2.1). Once the gels had set, 100µL of McCoy's media was
pipetted onto the gels and incubated for 24 hours to allow the gels to equilibrate with
the media. The media was then removed and discarded.
To prepare gelatin hydrogels for cell seeding and the alamarBlue assay, 3%, 5% and
10% gelatin hydrogels were prepared in 18 wells of three 24-well plates, as described in
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Section 3.2.2 (Fig. 3.17). Next, 1mL of McCoy's media was pipetted onto the gels for 24
hours to permeate the gel with the media. HT29 cells were seeded in nine of the wells at
a density of 5 x10 4 cells per mL. The other gels were not seeded and were instead used
as controls to correct for any changes in media colour (Fig. 3.17). Next, nine wells of a
second plate were seeded with cells to use as a PS control. The plates were incubated at
37◦C and 5% CO2 for 20 hours.
Because the dierent gel concentrations could potentially alter the media colour,
200µL of media was transferred from the three 20 hour replicate wells of the 3%, 5%,
10% plates and control gels to a 96-well plate to take into account the eect of the media
on the uorescence reading. A further 600µL was removed from the wells and discarded,
leaving 200µL in the wells. Following this, 20µL of alamarBlue reagent (Invitrogen, USA)
was added to the wells. It was used as an indicator of metabolic function and cellular
health. Plates were incubated for four hours at 37◦C and 5% CO2. Lastly, 200µL were
transferred from the plates to the 96-well plate. The plate reader (Molecular Devices
SpectraMax M5) was set to read uorescence at 530 nm excitation and 590 nm emission
and the plate was read. This process was repeated at 48 and 72 hours of incubation.
HT29 cells were seeded at 5 x10 4 per 200µL in nine wells containing gel in each plate.
Nine wells without gel were also seeded to use as polystyrene controls. Lastly, 200µL of
McCoy's media was pipetted onto three wells of each gel concentration, as well as three
wells of plain PS. After 20 hours incubation, 20µL of alamarBlue cell viability reagent
was added to the rst three wells of each gel concentration, the PS control and the wells
with plain media. The plate was incubated for four hours and then 200µL of media
was transferred from the wells to a new 96-well plate. The uorescence of the new plate
was read at 37◦C using the plate reader, at 530 nm excitation and 590 nm emission. The
above process was repeated at 40 and 60 hours, with the plate being read at 48 and 64
hours of incubation.
To statistically analyse the uorescent reading data, the data was log transformed
using the equation Y = Log2(Y); therefore, increasing the distance between small values
and decreasing the distance between large values in the dataset. A two-way repeated
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measure analysis of variance (2-way RM ANOVA) was carried out on the transformed
data. This determined whether there was a signicant dierence between the mean
cellular metabolism of HT29 cells on dierent concentration gelatin and collagen hydrogels
over a 72 hour time period. Cellular metabolism was based on the relative uorescent
units (RFUs) obtained during experimentation. Lastly, a Tukey's multiple comparison
test was carried out to determine whether there were any signicant dierences between
the mean cellular metabolism of HT29 cells on specic collagen and gelatin hydrogels.
Figure 3.17: Set up of hydrogels and cells in a PS 24-well plate.
3.8 HT29 cellular morphology on collagen and gelatin
hydrogels
To investigate cellular morphology of HT29 cells on the hydrogels, 3%, 5% and 7% colla-
gen hydrogels were prepared according to Section 3.2.1. Next, 3%, 5% and 10% gelatin
hydrogels were prepared and sterilised under UV, according to Section 3.2.2. Following
this, 3mL of each gel was transferred using a 5mL syringe and 21-gauge needle into
three 35mm by 23mm uorodishes (World Precision Instruments, USA), to a total of
18 separate dishes. The gels were carefully spread across the glass dish surfaces using
the slanted needle head. Cells were then sub-cultured according to Section 3.4 and were
seeded at 5 x10 4 cell per mL into three dishes with gels and one PS dish as a control.
Dishes were incubated at 37◦C and 5% CO2 for 24 hours. Cell morphology was then vi-
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sualised without any cell stains using the phase contrast setting of a confocal microscope
(Leica TCS SP5) at 24 and 72 hours of incubation. The 20 x dry lens (NA 0.50), 40 x dry
lens (NA 0.75) and 63 x oil immersion lens (NA 1.40) were used.
3.9 Contact angle of water on hydrogels
The contact angle (CA) (denoted θ) is the angle between a solid surface and a liquid-
vapour interface, and describes the wettability of the solid surface [83]. Measurements of
CA are achieved through the application of a liquid, most often water, to a surface. At a
specic pressure and temperature, a given solid surface has a unique CA. In this thesis,
CA was used as a measure of the level of hydrophobicity or hydrophilicity of collagen and
gelatin and hydrogels. This was used to determine which gel would be most appropriate
as a cell substrate. Studies have suggested that polymers with a water CA between 45◦
and 75◦ show optimal cellular adherence [83].
3.9.1 Contact angle of water on collagen hydrogels
PDMS was made, as described in Section 3.1.4 and was poured into an Omnitray. Once
cured, the PDMS was cut into 2 x 2 cm squares using a guillotine. Following this, 3%,
5% and 7% collagen gels were made, as described in Section 3.2.1. Next, 2 x 2 cm PDMS
squares were treated in the plasma asher to reduce the surface hydrophobicity. The pulse
ratio was set to 50, oxygen was supplied at 5 sccm, power was 255W and ashing time was
one minute. Once treated, 200µL of each gel concentration was pipetted on top of each
PDMS square and spread out using the pipette tip to form an even layer. Squares were
left at room temperature for ten minutes, followed by a ten minute incubation period in
an incubator at 37◦C and 5% CO2.
A telescopegoniometer (CAM 2008, KSV) was used to measure the water CA of the
hydrogels. It was calibrated using a 4mm metal ball, followed by the placement of a
PDMS square on the telescopegoniometer stage. All measurements were made using the
static, sessile drop mode. The frame interval was set to three seconds and the number of
frames was set to 30 frames. A small droplet of DI-water was dropped onto the hydrogel
surface and the tangent of the sessile drop prole was aligned using a camera and the
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CAM 2008 software package. The CA was measured by geometrically measuring the
angle between the water droplet and the surface of the hydrogel on both sides of the
droplet. The CA was measured for all three collagen hydrogels by measuring the CA of
three separate gel disks three times each.
3.9.2 Contact angle of water on gelatin hydrogels
To measure the CA of gelatin hydrogels, 3%, 5% and 10% gelatin hydrogels were prepared
in 85 x128mm cell culture omnitrays, as described in Section 3.2.2. A 14mm metal
holepunch was used to cut disks in the gels. The telescopegoniometer was calibrated
using a 4mm metal ball, followed by the placement of a gelatin disk on a glass slide,
which was then placed on the telescopegoniometer stage (Fig. 3.18). Measurements were
taken, as described above, and the tangent of the sessile drop prole was aligned using a
camera and the CAM 2008 software package (Fig. 3.19). The CA was measured for all
three gelatin hydrogels by measuring the CA of three separate gel disks three times each.
While each gel was expected to have a unique CA, data was collated to check whether CA
measurements converged to a specic angle range for each gel. The same measurement
process was also used to nd out the CA of water on the PDMS control.
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Figure 3.18: Contact angle measurement set up, with the placement of the needle
directly above the centre of a gel disk.
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Figure 3.19: Measurement of the contact angle of water on a 10% gelatin hydrogel,
using CAM2008 software. The left CA (θL) was 81.77
◦ and right measured CA (θR)
was 77.57◦, as denoted in the right panel in blue.
3.10 Seeding HT29 cells in LOC devices
HT29 cells were counted, as described in Section 3.4, and diluted to a concentration of
5 x10 4 per mL. Next, sterilised LOC devices were placed in a plastic container, and 5µL
of the diluted cell suspension was seeded into each lumen of each device (250 cells total in
5µL media) and immediately incubated at 37◦C for 25 minutes. The LOC devices were
then ipped upside down to achieve a uniform coating of cell in the lumens. Flipping was
repeated twice for each side.
3.11 Pump system for media ow through LOC devices
To set up the pump system that was used to provide fresh, supplemented media to
cells growing inside a LOC device, a small lathe with a circular saw attachment was
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used to cut the plastic Luer-locks o a blunt-ended 14-gauge needle (inner diameter =
1.6mm) (Techcon, USA) and a blunt-ended 18-gauge needle (inner diameter = 0.838mm)
(Terumo, Mcfarlane, AU), leaving the straight cut metal components. Next, a 1mL sy-
ringe was placed in the holder of a syringe pump (NE-4000 Two Channel Syringe Pump
Multi-Phaser). A threaded adapter (0.040-inch) (IDEX Health and Science, USA) was
used to attach 15 cm of Tefzel tubing (Kinesis, AU) to the syringe. The end of the tubing
was attached to a angless tting nut (IDEX Health and Science, USA) with a blue fer-
rule (1 / 16-inch) (IDEX Health and Science, USA) and was twisted into a shut o valve
(IDEX Health and Science, USA), as shown in Figure 3.20.
On the other side of the shut o valve, another tting nut with blue ferrule was
attached to a new 10 cm piece of Tefzel tubing, which was run from the other end of the
shut o valve into a 3 cm piece of thicker exible tubing (Tygon, Thermo Fisher, NZ)
(Fig. 3.20). This tubing was used as a sleeve to hold the 14-gauge needle in one end of
the LOC device through the 2mm hole that had been made with the holepunch, as shown
in Figure 3.20. On the other side of the device, the 18-gauge needle was held in the 1mm
hole using the same sleeve set up. Another shut o valve was attached to a tting nut
and blue ferrule, with a 10 cm piece of Tefzel tubing. The tubing ran into a fourth tting
nut and blue ferrule, which was twisted in to a threaded adapter (0.040-inch) (IDEX
Health and Science, USA). The adapter was then attached to a microuidic Eppendorf
reservoir (Elveow, Darwin Microuidics, FR) and the tubing was run into the bottom
of the 1.5mL Eppendorf containing supplemented McCoy's media (Fig. 3.20).
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Figure 3.20: Set-up of pump system to deliver fresh media to cells growing in the
LOC device.
3.11.1 Flow rate of media through the LOC lumens
The optimum ow rate of McCoy's media was found by testing dierent ow rates through
the lumens of LOC devices which had been seeded with HT29 cells. Cells were seeded in
the devices according to Section 3.10 and then the pump system was set up, as described
above. Media was drawn from the reservoir, through the lumen and into the syringe at
ow rates of 3, 4, 5, 6, 7, and 8µL per hour. Each ow rate was tested in a new LOC
for a total of three hours each, and the devices were checked under a light microscope
(Magnication 10 x, NA 0.25) (Nikon Eclipse Ts2) to observe whether cells had been
dislodged from the inner lumen surface by the sheer stress of the media. The optimum
ow rate was found to be 5µL per hour. The pump system was run in reverse to draw
media through the channel from the reservoir, at 1mL per minute until the media had
lled the tubing up to the device. The rate was then lowered to 5µL per hour so that
the cells inside the lumen of the LOC device would not be disturbed by shear stress of
the media owing through the channel.
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3.12 Bacteroides fragilis toxin (BFT)
To obtain the toxin, B. fragilis strain 86-5443-2-2 cells, which express the bft-2 toxin
isotype were grown for three days in 200mL of broth medium (brain heart infusion base
containing yeast extract, vitamin K, hemin and L-cysteine in a microaerobic environment
at 37◦C [84]. The resultant cultures were centrifuged at 2330 rpm for ten minutes to pellet
cells. The supernatant was subjected to a second round of centrifugation and passed
through a 0.22µm lter to remove any residual bacteria, before the addition of solid
(NH 4) 2 SO4 at full 60% (w/ v) saturation. After gentle mixing at 4
◦C for 90 minutes,
the solution was centrifuged at 3000 rpm for 40 minutes. The resulting pellet was dissolved
in PBS and any residual insoluble material was removed by centrifugation at 10,000 rpm
for ten minutes at 4◦C [85]. BFT activity in the precipitated protein was conrmed by
adding serial dilutions in cell culture media with the addition of 1% FBS to HT29 cells,
with greater than 50% cell rounding over time used to indicate the toxigenic eect [86].
As a negative control, the supernatant from non-toxigenic B.fragilis (NTBF) grown in
broth culture was collected.
3.13 Immunostaining for E-cadherin in HT29 cells
For immunostaining, HT29 cells (5 x 10 4 per mL) were grown in glass uorodishes and in
uorodishes coated with 5% gelatin hydrogels for 96 hours. The cells were then xed with
1% formaldehyde in PBS for 15 minutes at room temperature. The xative solution was
discarded and the cells in each dish were washed three times with ice cold PBS, with ve
minutes per wash. The cells were then incubated with 1mL of blocking buer (100µL
of 1% bovine serum albumin (BSA) dissolved in 900µL of PBS-Tween (1% BSA + 0.1%
Tween)) for one hour at room temperature. The buer was then discarded.
For staining, the primary antibody (Anti-E Cadherin antibody [M168]-C-terminal)
(Abcam, AU) was diluted at a 1 / 100 ratio (5µL diluted in 500µL of 1% BSA). Cells
were incubated with 500µL of antibody solution and 200µL of PBST at 4 ◦C overnight.
The next day, the antibody solution was discarded from the uorodishes and they were
washed on a tilt shaker at 30 rpm (Heidolph Instruments Duomax 1030) three times for
ve minutes each with ice cold PBS. The secondary antibody (Goat Anti-Mouse IgG
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H&L, Alexa Fluor 488) (Abcam, AU) was diluted at a 1 / 250 ratio in 1% BSA (5µL
diluted in 1250µL of BSA). Cells in each dish were incubated with the antibody solution
for one hour in the dark at room temperature. Following this, the antibody solution was
discarded from each dish and the cells were washed three times on a tilt shaker at 30 rpm
for ve minutes each with ice cold PBS. Lastly, 1mL of PBS was pipetted on to the cells
to prevent them from drying out. To visualise the location and presence of E-cadherin,
stained HT29 cells were observed using the 63 x oil immersion lens and 20 x dry lens of a
confocal microscope (Leica TCS SP5), with the emission bandwidth (beginning to end)
set to 486 nm - 576 nm.
3.14 Observation of cell rounding in BFT-treated HT29
cells
The toxigenic eect of BFT is associated with a detectable change in cell morphology,
identied as cell rounding. Cells were grown in plain glass uorodishes and in uorodishes
coated with 5% gelatin hydrogel for 48 hours. Cells were then rinsed once with PBS to
remove all traces of supplemented media. BFT-rich supernatant from an enterotoxigenic
B. fragilis (ETBF) was diluted in McCoy's 5A media without the addition of FBS, at
a 1 : 35 ratio. BFT was then added to half of the dishes and incubated for three and a
half hours. The concentrated supernatant from a non-toxigenic B. fragilis (NTBF) was
similarly added to the other half of the dishes as the control, and was incubated for three
and a half hours. Light microscopy (Magnication 20 x, NA 0.45) (Nikon Eclipse Ts2)
was used to determine if approximately 50% toxin-mediated cell rounding was evident in
this time frame.
3.15 Detection of HT29 cell rounding and loss of E-
cadherin after application of BFT
To observe any cell rounding and the loss of E-cadherin after 12 and 24 and hours of in-
cubation with BFT-rich supernatant, HT29 cells were grown on 5% concentration gelatin
hydrogels for 48 hours, followed by treatment with BFT-rich supernatant for both 12
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and 24 hours at 37◦C and 5% CO2, as described in Section 3.14. Following this, the cells
were then xed and stained for E-cadherin, as described in Section 3.13. To obtain a
better visualisation of the cells before and after the application of BFT-rich supernatant,
the cell nuclei were then stained using DAPI (2µg /mL of 0.1% PBS-tween), by adding
1mL of DAPI solution to the dishes. The cells were left to incubate for one hour at room
temperature and the stain was then discarded and the cells were washed three times
with ice cold PBS on a tilt shaker at 30 rpm, ve minutes each wash. The xed cells
were then imaged using the 20 x dry lens (NA 0.50) and 63 x oil immersion lens (NA
1.40) a confocal microscope (Leica TCS SP5) to identify any loss of E-cadherin in the
samples treated with BFT-rich supernatant. The emission bandwidth of the microscope
(beginning to end) was set to 420 nm - 493 nm. As a control, HT29 cells that were grown
for 48 hours were then treated with concentrated supernatant from NTBF for 12 and 24





4.1 Adherence of HT29 cells on polystyrene, PDMS
and gelatin thin lms
The ability of HT29 cells to adhere to PDMS (used as the main body of the LOC devices
in this study) and polystyrene (PS) was compared to the ability of cells to adhere to
PDMS and PS coated with a 0.1% gelatin solution over time. Paired t-tests were carried
out to investigate whether there were signicant dierences in the means of adherent and
non-adherent cells on the four dierent surfaces over a 72 hour incubation period.
HT29 cells readily adhered to the PS surface and remained adherent after 72 hours
of incubation, with cell numbers increasing over time. There was a signicant dierence
between adherent and non-adherent cells on the PS surface (p-value = 0.033), as shown in
Figure 4.1a. In contrast, a 0.1% gelatin thin lm appeared to aect HT29 cell adherence
over time. Whereas all cells were adherent at 24 hours of incubation, counts revealed that
63% of the cells were no longer adherent at 72 hours of incubation, as shown in Figure
4.1b). A paired t-test indicated no signicant dierence in the means of adherent and
non-adherent cells grown on PS coated with gelatin after 72 hours of incubation (p-value
= 0.079) (Fig. 4.1b).
In contrast, HT29 cells cultured on PDMS failed to adhere after 72 hours, as shown
in Figure 4.2a. On the contrary, 75% of cells added to PDMS coated with a 0.1% gelatin
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thin lm were adherent after this period of time, as shown in Figure 4.2b). A paired t-test
indicated no signicant dierence between the means of adherent and non-adherent cells
grown on PDMS coated with 0.1% gelatin thin lms over 72 hours (p-value = 0.77).
Images taken after trypsinisation showed that some cells were still adherent to both
the PS and PDMS surfaces that were coated with 0.1% gelatin thin lms, as shown in
Figures 4.3a and 4.3b). While this observation suggested that adherent cell numbers were
likely to be articially low, it also clearly showed that a thin lm of gelatin appeared to
facilitate the adherence of HT29 cells to the PDMS surface over time.
Figure 4.1: Mean cellular adherence of HT29 cells on (a) PS and (b) PS coated with
a 0.1% gelatin thin lm over a 72 hour time period.
Figure 4.2: Mean cellular adherence of HT29 cells on (a) PDMS and (b) PDMS
coated with a 0.1% gelatin thin lm over a 72 hour time period.
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(a) (b)
Figure 4.3: HT29 cells grown on (a) PS coated with a 0.1% gelatin thin lm and
(b) PDMS coated with a 0.1% gelatin thin lm were observed to have remained
adherent after trypsinisation, using the 10 x objective lens (NA 0.25) of a light
microscope.
4.1.1 Cell morphology on polystyrene, PDMS and gelatin thin
lms
HT29 cells grown on PS and on PS coated with gelatin thin lms showed evidence of
conuency after 72 hours of incubation, as shown in Figure 4.4a and 4.4b. In contrast,
HT29 cells grown on PDMS and PDMS coated with gelatin thin lms appeared to form
rounded, three-dimensional cell clusters over the same period of time. The cell clusters
on PDMS were observed to be non-adherent, as shown in Figure 4.5a. Cells grown on
PDMS coated with a 0.1% gelatin thin lm were observed to have a mixed population of
adherent and non-adherent cells, as shown in Figure 4.4b.
(a) (b)
Figure 4.4: HT29 cells had formed large, adherent, conuent layers when they were
observed on (a) PS and (b) PS coated with gelatin after 72 hours of incubation.
Cells were observed using the 10 x objective lens (NA 0.25) of a light microscope.
52
(a) (b)
Figure 4.5: HT29 cells had formed rounded, clustered morphologies after 72 hours
when they were observed on (a) PDMS and (b) PDMS coated with 0.1% gelatin
thin lms. Cells were observed using the 10 x lens (NA 0.25) of a light microscope.
4.2 Investigation of collagen and gelatin hydrogel for-
mation for potential use in LOC devices
The objective in creating the PDMS LOC devices was to mimic the tubular architecture
of the human gut and so HT29 cells were needed to adhere around the periphery of the
lumen inside the devices. Because collagen is an abundant protein in the human gut and
has been shown to facilitate cellular adhesion, it was thought that a collagen hydrogel
could be used to facilitate HT29 cellular adhesion in the LOC devices [87]. Gelatin is
an irreversibly hydrolysed form of collagen, which has also been found to aid cellular
adhesion, as described in Section 4.1. It was therefore thought that a gelatin hydrogel
could also be used to ll the LOC devices, form lumenal structures and facilitate HT29
cell adhesion.
As described in Section 3.2.1, 3%, 5% and 7% collagen hydrogels were made. All three
wells of each dierent concentration formed solid hydrogels, and the 7% hydrogel was the
most solid in comparison to the other two. This was expected because the 7% hydrogel
contained the most collagen brils. The 1%, 2%, 3%, 4%, 5% and 10% concentration
gelatin hydrogels in this study were made according to Section 3.2.2. The 3%, 4%, 5%
and 10% solutions formed solid hydrogels, whereas the 1% and 2% solutions did not form
solid hydrogels. To determine which gelatin hydrogel would be most appropriate to use
53
in the LOC devices, HT29 cell metabolism and morphology was investigated on the 3%,
5% and 10% concentration hydrogels, as described in Sections 4.3.2 and 4.5.
4.3 Alamar blue assay of HT29 cellular metabolism on
collagen and gelatin hydrogels
To identify how metabolically active HT29 cells were on collagen and gelatin hydrogels,
the alamarBlue cell viability reagent was used. Cells grown in the wells of a 96-well plate
reduced resozurin (blue in colour) to highly uorescent resorun (red in colour) by redox
power over a four hour time period. The uorescence of the media in the wells of the
plate was then measured using a plate reader, with an excitation between 530560 nm
and an emission at 590 nm. The intensity of the measured uorescence was proportional
to the number of living cells respiring in each well [88].
4.3.1 HT29 cellular metabolism on collagen hydrogels
The log transformation, as described in Section 3.7, resulted in an even distribution of
residual values, as shown in Figure 4.6. A 2-way RM ANOVA indicated that the combi-
nation of incubation time and collagen hydrogel concentration had no signicant eect on
the mean cellular metabolism of HT29 cells after 72 hours of incubation (p-value = 0.57)
(Fig. 4.7). The test indicated a signicant eect of time on mean cellular metabolism of
HT29 cells (p-value = 0.014), and no signicant eect of hydrogel concentration on mean
cellular metabolism (p-value = 0.94). A Tukey's multiple comparison test indicated no
signicant dierence between the mean cellular metabolism of HT29 cells on all combi-
nations of collagen hydrogel types at 24, 48 and 72 hours incubation (p-value > 0.05), as
shown in Figure 4.7.
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Figure 4.6: Residual plot of transformed relative uorescence values of HT-29 cells
on dierent concentration collagen hydrogels over a 72 hour time period.
Figure 4.7: Mean cellular metabolism of HT29 cells on 3%, 5% and 7% collagen
hydrogels and PS control over a 72 hour time period.
4.3.2 HT29 cellular metabolism on gelatin hydrogels
The log transformation, as described in Section 3.7, resulted in an even distribution of
residual values, as shown in Figure 4.8. A 2-way RM ANOVA indicated that the combi-
nation of incubation time and gelatin hydrogel concentration had no signicant eect on
the mean cellular metabolism of HT29 cells after 72 hours of incubation (p-value = 0.73)
(Fig. 4.9). The test indicated a signicant eect of time on mean cellular metabolism
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of HT29 cells (p-value = 0.0003), and no signicant eect of hydrogel concentration on
mean cellular metabolism (p-value = 0.22). A Tukey's multiple comparison test indi-
cated no signicant dierence between the mean cellular metabolism of HT29 cells on all
combinations of gelatin hydrogel types at 24 and 48 hours incubation (p-value > 0.05),
as shown in Figure 4.9.
Figure 4.8: Residual plot of transformed relative uorescence values of HT-29 cells
on dierent concentration gelatin hydrogels over a 72 hour time period.
Figure 4.9: Mean cellular metabolism of HT29 cells on 3%, 5% and 10% gelatin
hydrogels and PS control over a 72 hour time period.
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4.4 Contact angle measurements of water on collagen
and gelatin hydrogels
The contact angle (CA) (denoted θ) is the angle between a solid surface and a liquid-
vapour interface. In this study, the CAs of 3%, 5% and 7% concentration collagen hydro-
gels, as well as 3%, 5% and 10% concentration gelatin hydrogels, were measured. This was
to identify the level of hydrophobicity or hydrophilicity of each hydrogel surface, which
was used to determine which gel would be most appropriate as a substrate for HT29 cells.
As mentioned in Section 3.9, previous studies suggested that polymers with water CA
between 45◦ and 75◦ show optimal cellular adherence [83]. In this study, the CA of water
on gelatin and collagen hydrogel surfaces were calculated from the measured angles. An
ordinary one-way analysis of variance (ANOVA) was carried out to determine whether
there were signicant dierences between the mean CA of DI water on both gelatin
and collagen hydrogel surfaces. A Brown-Forsythe test was used to investigate whether
the variation within the dierent hydrogel groups and PDMS control were equal or not.
Lastly, a Tukey's multiple comparison test was carried out to determine whether there
were any signicant dierences between the mean CA of DI water on specic hydrogels
in the two analyses.
4.4.1 Contact angle of water on collagen hydrogels
The 3% collagen hydrogel had a mean CA of 34.9◦, the 5% hydrogel had a mean CA of
32.2◦ and the 7% hydrogel had a mean of 43.9◦, as shown in Figure 4.11. An ANOVA
indicated a signicant dierence in the mean CA of DI water on the 3%, 5%, 7% collagen
hydrogels and the PDMS control (p-value < 0.0001). The R 2-value was 0.91; therefore,
90% of the variation between the mean contact angle of DI water on the dierent colla-
gen hydrogels can be explained by this test. A Brown-Forsythe test showed no signicant
dierence in the variance between the groups (p-value = 0.19). Therefore, the standard
deviations were the same for the dierent groups (p-value < 0.05).
A Tukey's multiple comparison test was carried out to investigate whether there was
a signicant dierence between the mean CA of DI water on specic hydrogels in the
analysis. It indicated no signicant dierence between the mean CA of the 3% and 5%
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collagen hydrogels (p-value = 0.93), no dierence between the mean CA of the 3% and 7%
collagen hydrogels (p-value = 0.22) and no signicant dierence between the mean CA of
the 5% and 7% hydrogels (p-value = 0.066). However, there were signicant dierences





Figure 4.10: DI water droplets on dierent concentration collagen hydrogels and a
PDMS control were used to calculate the CA (denoted in yellow) of each hydrogel
surface. (a) CA of water on a 3% collagen hydrogel. θL = 24.4
◦. θR = 26.6
◦. (b) CA of water
on a 5% collagen hydrogel. θL = 20.4
◦. θR = 19.5
◦. (c) CA of water on a 7% collagen hydrogel.
θL = 20.2
◦. θR = 17.3
◦.
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Figure 4.11: Mean contact angle of DI water on PDMS, 3%, 5% and 7% collagen
hydrogels, and PDMS control.
4.4.2 Contact angle of water on gelatin hydrogels
The 3% gelatin hydrogel had a mean CA of 77.2◦, the 5% hydrogel had a mean CA of
64.4◦ and the 10% hydrogel had a mean of 75.1◦, as shown in Figure 4.13. An ANOVA
indicated a signicant dierence in the mean CA of DI water on the 3%, 5%, 10% gelatin
hydrogels and the PDMS control (p-value < 0.0001). The R 2-value was 0.55; therefore,
55% of the variation between the mean contact angle of DI water on the dierent gelatin
hydrogels can be explained by this test. A Brown-Forsythe test showed no signicant
dierence in the variance between the groups (p-value = 0.14). Therefore, the standard
deviations were the same for the dierent groups (p-value < 0.05).
A Tukey's multiple comparison test indicated no signicant dierence between the
mean CA of the 3% and 5% hydrogels (p-value = 0.12), no dierence between the mean
CA of the 3% and 10% hydrogels (p-value = 0.98) and no signicant dierence between
the mean CA of the 5% and 10% hydrogels (p-value = 0.24). However, there was a
signicant dierence in the mean CA between the 3% hydrogel and PDMS (p-value =
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0.01), the 5% hydrogel and PDMS (p-value < 0.0001) and between the 10% hydrogel and
PDMS (p-value = 0.0042) (Fig. 4.13).
(a) (b)
(c) (d)
Figure 4.12: DI water droplets on dierent concentration gelatin hydrogels and a
PDMS control were used to calculate the CA (denoted in yellow) of each hydrogel
surface. (a) CA of water on a 3% gelatin hydrogel. θL = 75.8
◦. θR = 71.7
◦. (b) CA of water
on a 5% gelatin hydrogel. θL = 56.3
◦. θR = 56.3
◦. (c) CA of water on a 10% gelatin hydrogel.
θL = 90.6
◦. θR = 86.5
◦. (d) CA of water on PDMS. θL = 92.6
◦. θR = 88.0
◦.
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Figure 4.13: Mean contact angle of DI water on PDMS, 3%, 5% and 10% gelatin
hydrogel disks, and PDMS control.
4.5 HT29 cell morphology on collagen and gelatin hy-
drogels
Confocal microscopy was used to observe the morphology of HT29 cells grown on collagen
and gelatin hydrogels and compared to HT29 cells grown on glass. After 24 hours of




Figure 4.14: HT29 cellular morphology was observed on glass controls after (a) 24
hours and (b) 72 hours of incubation. Cells were observed using the 63 x oil immer-
sion objective lens (NA 1.40) of a confocal microscope.
After 24 hours of incubation, HT29 cells on both the 3% and 5% collagen hydrogels
exhibited spherical cell morphology and formed sparse clusters across the hydrogel sur-
faces (Fig. 4.15a and 4.15b). HT29 cells on the 7% collagen hydrogel also appeared to
exhibit spherical shaped morphology and appeared to be starting to form a conuent
layer across the hydrogel surface (Fig. 4.15c). After 72 hours of incubation, the cells
continued to exhibit spherical morphology on both the 3% collagen hydrogel (Fig. 4.16a)
and the 7% collagen hydrogel (Fig. 4.16c). Cells on both hydrogels formed dense clus-
ters and cells were observed to be on top of each other. HT29 cells on the 5% collagen
hydrogel exhibited a more normal epithelial morphology, where cells had started to form




Figure 4.15: HT29 cellular morphology was observed after 24 hours on (a) a 3%
collagen hydrogel, (b) a 5% collagen hydrogel and (c) a 7% collagen hydrogel, using




Figure 4.16: HT29 cellular morphology was observed after 72 hours on (a) a 3%
collagen hydrogel, (b) a 5% collagen hydrogel and (c) a 7% collagen hydrogel using
the 63x oil immersion objective lens (NA 1.40) of a confocal microscope.
Cells that were grown on the 3% and 5% hydrogels appeared to have formed small,
conuent clusters with cell-cell contacts (Fig. 4.17a and 4.17b). Cells grown on the 10%
hydrogel appeared to be more dispersed across the surface, and some cells had formed
lopodia to connect to each other, as shown in Figure 4.17c. After 72 hours of incubation,
cells that were grown on glass had formed conuent clusters, as shown in Figure 4.14b).
After 72 hours, cells that were grown on the 3%, 5% and 10% gelatin hydrogels appeared
to have formed large, conuent clusters across the surfaces, as shown in Figures 4.18a,
4.18b and 4.18c. The lopodia observed on the 10% gelatin hydrogel had dissapeared by
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this time point, as shown in Figure 4.18c.
(a) (b)
(c)
Figure 4.17: HT29 cellular morphology was observed after 24 hours on (a) a 3%
gelatin hydrogel using the 40 x dry objective lens (NA 0.75), (b) a 5% gelatin
hydrogel using the 40 x dry objective lens (NA 0.75) and (c) a 10% gelatin hydrogel




Figure 4.18: HT29 cellular morphology was observed after 72 hours on (a) a 3%
gelatin hydrogel, (b) a 5% gelatin hydrogel and (c) a 10% gelatin hydrogel using
the 20 x dry objective lens (NA 0.50) of a confocal microscope.
4.6 Fabrication of LOC devices
LOC devices were fabricated from PDMS, as described in Section 3.1. After plasma
bonding of the bottom and top layers of the chip parts with the PDMS rods inside, the
devices were lled with a 5% gelatin hydrogel. Once the hydrogels had set, the rods were
successfully removed from the 2mm hole-punched hole in the top chip layers. This left
hollow lumens for cell culture, as shown in Figure 3.13.
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4.7 Cell seeding in LOC devices and ow rate optimi-
sation
Cells were seeded and grown inside the 5% gelatin hydrogel lumens of LOC devices in an
attempt to form a conuent layer which coated the entire inner lumen surface. After two
hours of incubation, HT29 cells had adhered to the gelatin inner lumen surface inside the
LOC devices, as shown in Figure 4.19. The pump system was then set up, as described
in Section 3.11, to provide fresh media to the growing cells. Media ow rates through
the lumen of 8µL per hour or higher led to the dislodgement of all cells from the lumen
wall. Flow rates of 6µL and 7µL per hour had dislodged less cells. The optimum media
ow rate was 5µL per hour because the sheer stress of media passing through the lumen
was not enough to dislodge any of the cells, and because enough nutrients was still being
provided to the cells each hour in order for them to grow.
Figure 4.19: HT29 cells were observed to be adhered to the 5% gelatin hydrogel
lumen surface within a LOC device after two hours of incubation. Cells were observed
using the 10 x objective lens (NA 0.25) of a light microscope.
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4.8 Localisation of E-cadherin in HT29 cells
To investigate the presence and location of E-cadherin in HT29 cells grown on glass
and on 5% gelatin hydrogels, cells were xed and permeabilised prior to being immuno-
stained with a mouse anti-E-cadherin monoclonal antibody. E-cadherin was detected
using an Alexa uor 488-labelled secondary antibody (green), and was observed around
the periphery of HT29 cells grown on glass, as shown in Figure 4.20a and on 5% gelatin
hydrogels, as shown in Figure 4.20b. The E-cadherin staining was overlayed on the bright
eld images, which also showed that E-cadherin was located at the cell peripheries of cells
grown on glass (Fig. 4.21a) and on a 5% gelatin hydrogel (Fig. 4.21b).
(a) (b)
Figure 4.20: Localisation of E-cadherin (green) in HT29 cells was observed at the
peripheries of cells grown on (a) glass using the 63 x oil immersion objective lens
(NA 1.40), and (b) 5% gelatin hydrogels using the 20 x dry objective lens (NA 0.50)
of a confocal microscope. Dierent lenses were used because the hydrogel thickness aected
the distance that the lens could see through the sample.
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(a) (b)
Figure 4.21: Localisation of E-cadherin (green) in HT29 cells was over-layed on the
bright eld images. E-cadherin was observed at the peripheries of cells grown on
(a) glass using the 63 x oil immersion objective lens (NA 1.40), and (b) 5% gelatin
hydrogels using the 20 x dry objective lens (NA 0.50) of a confocal microscope.
Dierent lenses were used because the hydrogel thickness aected the distance that the lens
could see through the sample.
4.9 Eect of BFT on HT29 cells
To investigate whether BFT would lead to cell rounding, HT29 cells were incubated with
BFT-rich supernatant for three and a half hours. Approximately 50% of cells exhibited
rounding on glass and on 5% gelatin hydrogels, as seen in Figure 4.22. The concentrated
supernatant derived from a nontoxigenic B. fragilis (NTBF) was used as a control and
HT29 cells grown on glass or a 5% gelatin hydrogel showed no morphological changes
after three and a half hours of incubation with the supernatant derived from NTBF, as




Figure 4.22: Cell rounding, as indicated by red arrows, was observed after infection
with BFT-rich supernatant for 3.5 hours. (a,b) Infected HT29 cells grown on glass.
(c,d) Infected HT29 cells grown on 5% gelatin hydrogels. Images are representative of





Figure 4.23: No morphological changes were observed in HT29 cells grown on (a,b)
glass and (c,d) 5% gelatin hydrogels, which were treated with concentrated super-
natant derived from NTBF. Images are representative of three separate experiments and
were taken by using the 20 x dry objective lens (NA 0.50) of a confocal microscope.
Cell staining for E-cadherin (green) was carried out on BFT-treated HT29 cells and
on HT29 cells that were treated with supernatant derived from NTBF. This was to iden-
tify whether BFT was involved with the loss of E-cadherin over time. Nuclear staining
(blue) was also carried out to present a better visualisation of the cells before and af-
ter the application of BFT-rich supernatant and concentrated supernatant derived from
NTBF. HT29 cells on glass and 5% gelatin hydrogels were incubated with BFT and su-
pernatant derived from NTBF for 12 and 24 hours, followed by xation and staining, and
immunouorescent confocal microscopy, as described in Section 3.15.
After 24 hours, BFT-treated HT29 cells that were grown on glass and 5% gelatin
hydrogels exhibited cell rounding and the loss of E-cadherin. This was evident due to
the lack of green staining at the cell peripheries, as shown in Figures 4.24a and 4.24b. In
contrast, HT29 cells treated with supernatant derived from NTBF, that were grown on
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glass and 5% gelatin hydrogels, had staining of E-cadherin at the cell peripheries after
24 hours of incubation (Fig. 4.24c and 4.24d). Nuclei were observed in the cytosol of all
cells, as shown in Figures 4.24 and 4.26.
To better visualise the exact location of E-cadherin and nuclei in the HT29 cells that
were treated with BFT and supernatant derived from NTBF for 24 hours, the E-cadherin
and nuclear stain images were lay on top of the original bright eld images. As shown
in Figures 4.25a and 4.25b, BFT-treated HT29 cells on glass and 5% gelatin hydrogels
did not show the presence of E-cadherin at the cell peripheries. In contrast, HT29 cells
treated with supernatant derived from NTBF, that were grown on glass and 5% gelatin
hydrogels, showed the presence of E-cadherin at the cell peripheries. This was conrmed





Figure 4.24: After 24 hours, E-cadherin (green) was not present in BFT-treated HT29
cells grown on (a) glass and (b) a 5% gelatin hydrogel. E-cadherin was localised
at the cell peripheries of HT29 cells grown on (c) glass and (d) 5% gelatin hydro-
gel, which were treated with concentrated supernatant derived from NTBF. Nuclei
(blue) were observed to be present in the cytosol of cells treated with BFT (a,b) and
concentrated supernatant derived from NTBF (c,d). Images are representative of three





Figure 4.25: After 24 hours, the localisation of E-cadherin (green) and nuclei (blue)
were over-layed on the bright eld images. E-cadherin was not present in BFT-
treated HT29 cells grown on (a) glass and (b) a 5% gelatin hydrogel. E-cadherin
was localised at the cell peripheries of HT29 cells grown on (c) glass and (d) 5%
gelatin hydrogel, which were treated with concentrated supernatant derived from
NTBF. Nuclei were observed in the cytosol of cells treated with BFT (a,b) and
concentrated supernatant derived from NTBF (c,d). Images are representative of three
separate experiments and were taken using the 20 x dry objective lens (NA 0.50) of a confocal
microscope.
After 12 hours, BFT-treated HT29 cells that were grown on glass and 5% gelatin hy-
drogels exhibited cell rounding and the loss of E-cadherin. This was visualised by the lack
of green staining at the cell peripheries, as shown in Figures 4.26a and 4.26b. In contrast,
HT29 cells treated with supernatant derived from NTBF, that were grown on glass and
5% gelatin hydrogels, had the presence of E-cadherin staining at the cell peripheries after
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12 hours of incubation (Fig. 4.26c and 4.26d). Nuclei were observed in the cytosol of all
cells, as shown in Figures 4.26 and 4.26.
To better visualise the exact location of E-cadherin and nuclei in the HT29 cells that
were treated with BFT and supernatant derived from NTBF for 12 hours, the E-cadherin
and nuclear stain images were lay on top of the original bright eld images. As shown
in Figures 4.27a and 4.27b, BFT-treated HT29 cells on glass and 5% gelatin hydrogels
did not show the presence of E-cadherin at the cell peripheries. In contrast, HT29 cells
treated with supernatant derived from NTBF, that were grown on glass and 5% gelatin
hydrogels showed the presence of E-cadherin at the cell peripheries. This was conrmed





Figure 4.26: After 12 hours, E-cadherin (green) was not present in BFT-treated HT29
cells grown on (a) glass and (b) a 5% gelatin hydrogel. E-cadherin was localised in
HT29 cells grown on (c) glass and (d) 5% gelatin hydrogel, which were treated with
concentrated supernatant derived from NTBF. Nuclei (blue) were observed to be
present in the cytosol of cells treated with BFT (a,b) and concentrated supernatant
derived from NTBF (c,d). Images are representative of three separate experiments and were




Figure 4.27: After 12 hours, the localisation of E-cadherin (green) and nuclei (blue)
were over-layed on the bright eld images. E-cadherin was not present in BFT-
treated HT29 cells grown on (a) glass and (b) a 5% gelatin hydrogel. E-cadherin
was localised at the cell peripheries of HT29 cells grown on (c) glass and (d) 5%
gelatin hydrogel, which were treated with concentrated supernatant derived from
NTBF. Nuclei were observed in the cytosol of cells treated with BFT (a,b) and
concentrated supernatant derived from NTBF (c,d). Images are representative of three





5.1 Adherence and morphology of HT29 cells on polystyrene,
PDMS and gelatin thin lms
The adherence of HT29 cells was investigated on polystyrene (PS) well plates, PDMS, PS
and PDMS coated with gelatin thin lms. The aim was to identify whether gelatin could
increase cellular adherence on both surfaces. Cell morphology was also analysed using the
light microscope to identify whether cells were forming conuent layers after 24, 48 and
72 hours of incubation. All HT29 cells counted on PS after 72 hours were all adherent,
as shown in Figure 4.1a, and exhibited normal cellular morphology and conuence, as
shown in Figure 4.4a. This is consistent with previous literature, which showed that cells
form adhesions to tissue culture treated PS surfaces, and formed conuent layers after at
least 48 hours incubation, like the cells grown in the well plates used in this study [89, 90].
Cells grown on PDMS were non-adherent over the entire 72 hour incubation period,
as shown in Figure 4.2a. This was expected as PDMS is inherently hydrophobic, which
has been found to prevent cellular adhesion [91]. The cells also formed several three-
dimensional clusters, suggesting that cells were adhering to each other, rather than to
the PDMS surface (Fig. 4.5a). Several studies showed that surface treatment or modica-
tion of PDMS, such as plasma treatment, increased surface hydrophilicity and enhanced
cellular adhesion [92, 93, 94]. Conventional oxygen plasma treatment in a vacuum cham-
ber was found to decrease PDMS surface hydrophobicity and increase wettability, through
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the removal of organic surface contaminants [95]. Fritz and Owen (1995) showed that
after plasma treatment, low molecular weight material had diused through the PDMS
polymer matrix, which increase hydrophobicity and therefore led to an increase in contact
angle [96]. Tan et al., (2010) showed that hydrophobic recovery of PDMS was prevented
for weeks by storing the plasma treated PDMS in de-ionised water, which maintained
hydrophilicity [97]. To increase hydrophilicity of the PDMS surface in this study, the
PDMS could have been plasma treated prior to cell seeding, which may have increased
cellular adhesion and promoted cells to form a conuent layer, rather than clusters as
shown in Figure 4.5a. Hydrophilicity could have also been maintained over the 72 hour
period as the PDMS was immersed in media the whole time.
Cells grown on the gelatin coated PS and PDMS plates showed no signicant dif-
ference in the number of adhered and non-adhered cells after 72 hours of incubation, as
shown in Figures 4.1b and 4.2b. Normal cellular morphology and conuence was observed
prior to trypsinisation on the coated PS, as shown in Figure 4.4b. On the coated PDMS
plate, cells had formed large three-dimensional clusters, suggesting that some cells had
adhered to the gelatin surface and that other cells had grown on top of other cells to
avoid the surface (Fig. 4.5b). PDMS is known to be porous, so the gelatin may have
unevenly sunken in to the pores, leaving some areas of PDMS more exposed than others.
This suggested that cells had formed clusters to avoid hydrophobic areas between the
gelatin coating.
Cells were observed to remain adhered to the gelatin surface after trypsinisation, as
shown in Figures 4.3a and 4.3b). Previous literature identied that gelatin aided cellular
adhesion through linear arginine-glycine-aspartate (RGD) motifs [30] and that trypsin
acted as a proteolytic enzyme which cleaved peptides on the C-terminal side or arginine
or lysine. In this study, the cell count for adhered cells on PS and PDMS coated with
gelatin may have been higher if the cells were trypsinised for a time period longer than
ten minutes, as it would have allowed more time for the enzyme to cleave the RGD motifs
adhering the cells to the gelatin thin lms, therefore lifting more cells from the surface
for counting [98]. The coated PDMS plate could have also been plasma treated prior
to adding the gelatin thin lm. This would have made the PDMS surface less porous,
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preventing gelatin from unevenly sinking into it, thus forming an more even layer of
gelatin on the PDMS surface for cells to adhere to. The cells may have then formed a
conuent layer, similar to those seen in Figures 4.4b [96].
5.2 HT29 cellular morphology on collagen and gelatin
hydrogels
Cells grown on 3%, 5% and 7% collagen hydrogels exhibited cell rounding and the forma-
tion of 3D clusters on the collagen gel surfaces. Previous literature showed that brillar
collagen supports cellular adhesion through a subset of collagen-binding integrins [99].
Studies showed that HT29 cells were found to have high expression of the α1β1 and α2β1
integrins, and that α2β1 specically mediated adhesion of cells to type I collagen brils.
The binding of α2β1 may therefore possibly explain why cell clusters had adhered to the
collagen surfaces in this study [100, 101, 102]. Haier et al., (1999) showed that HT29
cellular adhesion to components of the extracellular matrix was mediated by dierent
integrins and was dependent on the substrate, such as type 4 collagen, laminin and -
bronectin [103]. Another study by Haier et al., (1999) showed that other collagen-binding
receptors, such as tyrosine kinases, aected and regulated intracellular signal transduc-
tion pathways, which in turn, regulated cell morphology and tumour growth of HT29 cells
[102]. The activity of collagen-binding receptors in this study may possibly explain why
the cells rounded up when grown on the three dierent concentration collagen hydrogels.
HT29 cells in this study exhibited normal morphology and conuence on 3%, 5% and
10% gelatin hydrogels after 72 hours incubation. These ndings were consistent with
previous literature, which identied that gelatin aids cellular adhesion through linear
arginine-glycine-aspartate (RGD) motifs, as stated in Section 5.1 [30]. To further study
HT29 cell conuence and morphology, integrin-mediated cell adhesion to the hydrogel
surfaces could be investigated. Previous studies used immunocytochemistry to stain and
localise dierent integrins, such as β1, α2, 3 and 6, in HT29 cells grown on collagen and
laminin [104, 103, 105]. Immunocytochemistry could therefore be used in the future to
investigate HT29 cell adhesion on the dierent hydrogels, and potentially explain why
cells rounded up on collagen hydrogels (Fig. 4.16) but not on gelatin hydrogels (Fig. 4.18).
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Another reason for the observed cell morphologies on the hydrogels may have been
due to the composition and cross-linking of the hydrogels. Previous literature showed
that these factors aected integrin-mediated cell adhesion and had the potential to alter
cellular binding and conuence across hydrogel surfaces [106]. Davidenko et al., (2016)
showed that the availability of integrin binding sites for HT1080, C2C12 L3 and Rugli cells
was strongly inuenced by the extent of collagen hydrogel cross-linking. Davidenko et al.,
(2016) suggested that cross-linking can aect the number of cell recognition sequences
that are important for cell-substrate interactions and binding. Other studies showed that
HT29 cells grown on top of type I collagen hydrogels, or inside type I collagen hydrogel
matrices, exhibited the formation of well-dened multi-cellular tumour spheroids, rather
than 2D monolayers [13, 107]. The previous literature may therefore explain why HT29
cells formed 3D clusters on the collagen hydrogels in this study [106].
A limitation of investigating HT29 cell morphology on the dierent concentration
collagen and gelatin hydrogels was that the hydrogel coatings in the bottom of the u-
orodishes may not have had an even thickness in comparison to one another. Although
3mL of each hydrogel was dispensed onto the bottom of each dish, as described in Sec-
tion 3.8, the spreading of the hydrogels across the glass surfaces may not have been even
in comparison to one another. This meant that there were likely some areas of hydro-
gel that were thicker than others, which in turn, may have aected cellular adhesion
and morphology. Three dierent objective lenses were used to image cell morphology,
as described in Section 3.8. This was because there were diculties with focussing on
clusters of HT29 cells on the dierent hydrogels, likely due to the diering thickness of
the hydrogels in each dish. If this experiment were to be repeated, less hydrogel could
be added to each uorodish, which would possibly allow the use of the same objective
lens for all of the imaging. The uorodishes could also be placed on a tilt angle shaker
to help spread the hydrogels evenly across the glass surfaces, before being incubated to
complete cross-linking.
To further investigate HT29 cell morphology on gelatin hydrogels, dynamic mechani-
cal analysis (DMA) could be carried out. DMA helps to identify the mechanical nature
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of hydrogel samples and works by clamping a sample into a sample holder of a dynamical
mechanical analyser machine. A sinusoidal force (stress) is then applied to the sample,
followed by measurement of the displacement or deformation of the sample. Obtaining
this information about the mechanical stress properties of the gelatin hydrogels would
help to further characterise them. It would also allow for potential alteration of hydrogel
composition to best mimic the composition of the human gut, which could potentially
help to make the LOC devices more biologically relevant.
5.3 Contact angle of water on collagen and gelatin hy-
drogels
The hydrophobicity and hydrophilicity of water on the 3%, 5% and 10% gelatin hydrogels,
and on the 3%, 5% and 7% collagen hydrogels was calculated by measuring the contact
angle (CA) of water droplets on the surfaces. Hydrogels that have high concentrations of
water show relatively low contact angles, indicating that the surfaces are hydrophilic [24].
It was therefore hypothesised that the 3% gelatin and collagen hydrogels would have the
lowest measured mean CAs. The lowest mean CAs in this study were measured on the
5% gelatin (θ = 64.4◦) and 5% collagen (θ = 32.2◦) hydrogels, with the 3% gelatin (θ =
77.2◦) and collagen (θ = 34.9◦) hydrogels having higher CAs (Fig. 4.13 and 4.11). These
results are consistent with those of Yasuda et al., (1994), which showed that the CA mea-
surement of a 15% solid gelatin hydrogel was created due to the attractive force between
the polymer molecules of the hydrogel sample and the sessile water droplets. They also
showed that the CA resulted from the change in the conguration of the hydrogel surface
molecules to reach equilibrium with the water droplet.
Hydrophobicity or hydrophilicity of hydrogels depends on the orientation of hydrophilic
moieties toward the hydrogel-air interface [24, 108]. Holly and Refojo (1975) observed a
low CA for water on the surface of a polyhydroxyethylmethacrylate hydrogel, by injecting
an air bubble beneath the hydrogel surface immersed in water [109]. Their results sug-
gested that at the hydrogel-water, interface the surface was hydrophilic, and at the the
hydrogel-air interface, the surface was hydrophobic [109]. The groups were most likely
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rotated and drawn into the mass of the hydrogel, thus lessening the number of hydrophilic
moeities at the hydrogel-air interface and hence decreasing surface hydrophilicity [109].
Other studies support the ndings of Holly and Refojo (1975), and have suggested that
hydrogel exposure to air with low humidity can lead to the re-orientation of hydrophilic
molecules in hydrogels with high water concentrations, leading to higher CA measure-
ments than expected [24, 110].
With regards to the 3% gelatin and collagen hydrogels in this study, the polymer
molecules within the gels may have been internally rotated toward the mass of the hy-
drogel disks, rather than facing toward the hydrogel-air interface. This likely meant that
less hydrophilic molecules were present at the surface, possibly explaining why a high
CA was measured for both gel types. If the CA measurements on the dierent gelatin
and collagen hydrogel concentrations were carried out again, air humidity would be need
to be taken into consideration. Measurements could be obtained in a temperature and
humidity controlled room, where the air humidity could be moderated to prevent the re-
orientation of hydrophilic molecules in the disks. Another approach would be controlling
the exposure of the hydrogel surfaces to air. Rather than having all gel disk samples
sitting on the bench when making single measurements, each sample could be kept in the
fridge until a measurement needed to be made.
5.4 AlamarBlue assay of HT29 cell metabolism on col-
lagen and gelatin hydrogels
The alamarBlue cell viability reagent was used to investigate the metabolic activity and
health of HT29 cells grown on gelatin and collagen hydrogel surfaces over a 72 hour in-
cubation period. Resazurin was the active reagent that was converted to resorun by
the reducing power of living cells [111]. Cell viability was then quantitatively measured
by measuring the uorescent wavelengths of the cell media after incubation with alamar-
Blue. HT29 cells grown on the PS controls, and on the 3%, 5% and 10% gelatin hydrogels
showed a signicant dierence in cellular activity over the 72 hour incubation period, with
a signicant decrease in activity over 72 hours (Fig. 4.9). Similarly, cells grown on the
PS controls and on the 3%, 5% and 7% collagen hydrogels showed a signicant dierence
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in cellular activity over time, with an increase in activity after 72 hours of incubation, as
shown in Figure 4.7. The hydrogel type and concentration had no signicant eect on
cellular activity over time, as shown in Figures 4.9 and 4.7.
AlamarBlue is known to act as an intermediate electron acceptor in the electron
transport chain. Previous studies showed that NADPH, FADH and NADH acted as
intermediate electron acceptors, which led to a conversion of resazurin to resorun in
living cells [112]. The results in this study are consistent with previous literature, which
showed that an increase in cell-cell contacts of adherent 3T3 cells led to a decrease in
ATP- and NAD-content, NAD-redox potential, lactate production, oxygen consumption,
[113]. Hahn et al., (1998) showed that SV40T-3T3 cells at conuent densities exhibited
low metabolic activity, with a decrease in NADH over time [113]. De Fries and Mitsuhashi
(1995) showed that cell density of peripheral blood mononuclear cells (PBMC) led to a
reduction in cellular metabolism. They observed a decrese in cellular proliferation when
the cell density was too high, which led to less reduction of alamarBlue than expected
[114]. This therefore supports the idea that in this study, the cells growing on the gelatin
hydrogels became less metabolically active over time due to the formation of cell-cell
contacts when the cells started to form conuent layers.
In this study, HT29 cells grown on the 3% and 7% collagen hydrogels formed small,
3D clusters after 72 hours of incubation, as shown in Figures 4.16a and 4.16c. HT29
cells grown on 5% collagen hydrogels formed 2D monolayers after 72 hours incubation,
as shown in Figure 4.16b. The cluster formations observed were consistent with previous
literature, which showed that cells grown in spheroids re-wired their metabolic networks
to support the biosynthetic and energetic demands of spheroid / tumour growth [115].
The observed increase in metabolism of cells on the 5% hydrogel was possibly due to an
increased energy demand over the 72 hour period, which was required for the migration
of individual cells into a sheet and the formation of cell-cell junctions, such as E-cadherin.
If the alamarBlue assay for cell metabolism and health was carried out again, NADH
could be used as a biomarker, and an NAD+ and NADH in each well with cells could
be quantied using a NAD/NADH colorimetric assay kit. Because NADH is a known
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intermediate electron acceptor from resozurin [112], disseminating the amount of NADH
in the samples over the 72 hour incubation period would help to provide further infor-
mation about the metabolic activity of HT29 cells on the dierent hydrogels. A smaller
incubation period, such as 48 hours could also be carried out, and alamarBlue measure-
ments could be taken more frequently, such as every 8 to 12 hours, rather than every 20
hours. This may enable a more distinct metabolic trend to be disseminated and provide
further information about HT29 cellular metabolism on the dierent hydrogels.
5.5 Seeding and growth of HT29 cells in LOC devices
Cells were seeded in the lumens of LOC devices at a density of 5 x 10 4 /mL. A total of
5µL of cell suspension was pipetted into each lumen, so there was an approximate total
of 50 cells seeded per 1µL of cell suspension. The pump system was then set up at a
ow rate of 5µL per hour, which enabled the growing cells to access nutrients from fresh
media, without being dislodged by sheer stress. The dimensions of the internal lumens
within the LOC devices were measured to calculate how many cells would be required to
coat the entire inner lumenal surface. The radius (r) of each lumen was 0.8mm and the
length (l) of each lumen was 10mm. The total surface area (Sa) inside of the lumen was
calculated using the equation, Sa = 2π r l. Surface area was calculated to be 50.3mm
2.
To calculate the area of a single HT29 cell which was in contact with the lumen
surface, the cube root of the cell size was calculated using the equation, 3
√
cell size. The
known area of HT29 cells was 11µm 3, and cell size was calculated to be 2.2µm 2. To
calculate the total number of cells required to coat the entire inner lumen surface, the
total surface area of the lumen was divided by the area of a single cell in contact with
the lumen surface.






The doubling time for HT29 cells was approximately 24 hours, and the cells in this
study were sub-cultured when they had reached 80% to 90% conuence, or when the cell
density was approximately 5 x 10 4 viable cells per cm 2. In this study, cells were seeded
in the LOC devices at a density of 50 cells per µL, with a total volume of 5µL. This
meant it would have taken approximately 17 days for cells to coat the entire inner lumen
surface. To coat the entire lumen surface with cells over a nine day period, 1mL of the
cell suspension left over from sub-culturing could have been centrifuged at 1000G for
three minutes to pellet the cells. The pellet would have contained approximately 50,000
cells, which could have been re-suspended in 5µL of McCoy's media and then carefully
seeded into the lumen of a LOC. At this seeding concentration, it would have taken ap-
proximately nine days to coat the entire inner lumen surface.
In this study, HT29 cells never fully coated the inner lumen surface because there were
issues with the pump system. Specically, the needle heads which were inserted into the
holes of the LOC devices became slightly dislodged / disconnected over time, which led
to media leakage and allowed air bubbles to get into the lumens. This in turn led to the
lumens drying out over a short amount of time, which led to cell death. In microuidics,
there are three main approaches to form interconnections between LOC devices and tub-
ing. These include the use of glue connectors on the LOC surfaces, the use of rubber
O-rings, clamps or screws to form press-t connections, and lastly, the direct insertion of
tubes into LOC devices [116]. Wang et al., (2014) showed that a glued-tubing interface
helped to prevent leakage of liquids from the channels within a PDMS LOC, which were
then able to sustain inlet pressures of up to 600kPa [116].
Methodologically, Wang et al., (2014) applied a small amount of glue to the end of
a plastic tube, which was then inserted into the LOC inlet. Following this, an uncured
layer of PDMS was poured on top of the PDMS chip and was baked to solidify the PDMS
[116]. In this study, HT29 cells were already adhered inside the lumens, and so the second
layer of PDMS could not have been added and baked, as that would have dried out the
hydrogel lumen and killed the cells. Wang et al, (2014) showed that at a ow rate of
10mL per hour, leakage of coloured dye occurred from a micro-channel of a LOC which
had been glued, but did not have the extra layer of PDMS added [116]. Their study
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suggested that leakage from the needle inlets may not have occurred at far lower ow
rate, such as the ow rate of 5µL per hour which was used in this study. This suggests
that to avoid media leakage in this study, the needle heads could have had glue applied
to the ends before insertion into the LOC devices. Another reason why leakage may have
occurred in this study was possible movement of the rigid Tefzel tubing which carried
media from the reservoir into the LOC devices, and back out into the syringe. To prevent
movement, the tubes could have been taped to the incubator shelf surface. This may
have made it lessened tube movement and prevented slight dislodgement of the needles
inserted in the LOC devices.
Future work will focus on applying BFT to HT29 cells grown inside the lumens of the
LOC devices, through a passive pumping method. Immunostaining of E-cadherin, nuclei
and actin could then be carried out, followed by immunouorescent confocal microscopy,
in order to detect and localise the aforementioned cell parts inside the LOC lumens.
Future work could also focus on the E-cadherin /β-catenin complex, because it has been
known to play a major role in tumour suppression. As seen in Figure 1.2, The intracellular
domain of E-cadherin is bound to β-catenin. Several studies used western blotting and
immunocytochemistry to show that loss of E-cadherin through the mechanism of BFT, led
to the promotion of β-catenin release [117]. This has been associated with the facilitation
of the epithelial-mesenchymal transition (EMT), which is known to play a role in cancer
progression [117, 118].
5.6 E-cadherin localisation and eect of BFT on HT29
cells
HT29 cells grown on glass and 5% gelatin hydrogels were incubated with the non-toxigenic
Bacteroides fragilis toxin (NTBF) control and BFT for three and a half hours. NTBF-
treated HT29 cells on both the glass and hydrogel substrates exhibited no changes in
morphology, as seen in Figure 4.23. BFT-treated cells grown on glass and hydrogel ex-
hibited approximately 50% cell rounding after three and a half hours, as seen in Figure
4.22. HT29 cells on glass and hydrogel were then treated with NTBF and BFT for both 12
and 24 hours. During immunocytochemistry by immunouorescent confocal microscopy,
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the cells treated with NTBF exhibited the presence of cell nuclei (blue), which were lo-
calised in the cell cytosols, and E-cadherin (green), which were localised at the cell-cell
interfaces, as observed in Figures 4.26c, 4.26d, 4.24c, 4.24d. These results are consistent
with previous literature, which stated that NTBF was non-toxigenic, and showed that
NTBF did not induce the loss of E-cadherin in HT29 cells [71, 66, 119].
The BFT-treated cells on glass and hydrogel exhibited the presence of cell nuclei
(blue), which were localised in the cell cytosols. There was a clear loss of E-cadherin,
because no green ourescence was observed at the HT29 cell-cell interfaces, as observed in
Figures 4.26a, 4.26b, 4.24a, 4.24b. These results are consistent with previous literature,
which showed that HT29 cells incubated with BFT lost the E-cadherin cell-cell junctions
[72, 75, 120, 46]. Wu et al., (1998) treated HT29 /C1 cells with BFT (5 nM) for both
30 and 60 minutes, followed by cellular xation with formaldehyde (10%), immunostain-
ing of E-cadherin and immunouorescent confocal microscopy (ICM) [72]. They showed
that the BFT-treated cells exhibited cell rounding and had lost their E-cadherin junc-
tions after both 30 and 60 minutes of incubation with BFT. A later study by Wu et
al., (2003) also used ICM and showed that HT29 /C1 cells had become swollen and had
lost E-cadherin junctions after treatment with BFT (100 ng /mL). They found that BFT
rapidly cleaved E-cadherin and complete degradation was observed after one hour of in-
cubation with BFT [75]. Koshy et al., (1996) showed that BFT (1µg) stimulated a 10
to 25% increase in the cell volume of HT29 /C1 cells after 24 hours of incubation with
BFT [121]. Other studies have used western blotting to show that cells treated with BFT
lost the E-cadherin proteins [122, 46]. Hwang et al., (2013) treated HT29 /C1 cells with
puried BFT (100 ng /ml) for 24 hours and western blotting showed that E-cadherin was
not present [46].
A limitation of the staining process was that attempted actin microlament staining
did not work, which meant the distribution of actin before and after application of BFT
could not be observed. Cellular xation with 1% formaldehyde may have caused cellular
contraction and changed the actin distribution in the cells. Future work will therefore
focus on optimising the cellular xation process and cell staining of actin, nuclei and E-
cadherin. A previous study xed HT29 cells with pre-cooled acetone and methanol (50 : 50
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(v / v)) for 45 minutes, followed by immunostaining of E-cadherin and nuclei [123]. The
use of acetone and methanol may have been gentler on the cells during xation. In future,
this may potentially preserve the cells better than the 1% formaldehyde solution used in
this study. Another limitation was that only the 20 x dry objective lens (NA 0.50) of a
confocal microscope was able to be used for imaging. This was likely because the 5%
gelatin hydrogel surface in each uorodish was unevenly spread, as described in Section
5.2, which meant that higher objective lenses were unable to see through the thicker parts
of each hydrogel. As mentioned in Section 5.2, less hydrogel could be spread on the glass
dish surface, which may have enabled the use of a higher magnication objective lens.
This in turn would have provided higher resolution images of the E-cadherin and nuclei
staining of HT29 cells treated with BFT and NTBF.
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Chapter 6
Conclusions and Future Direction
Previous studies have identied a potential role of BFT in colon carcinogenesis, by which,
the binding of BFT to a colonic epithelial cell receptor triggers an intracellular signalling
cascade and induces cleavage of E-cadherin cell junctions in the intercellular space (Fig.
1.4). These in turn, lead to loss of cell polarity, cell rounding and eventually an increased
risk of cancer formation [73, 75, 76]. In the present study, a lab-on-a-chip device was
designed and fabricated, with the potential to model BFT as a possible driver of colon
carcinogenesis. The HT29 colorectal cancer cell line was used in this study because cells
exhibit a distinct change in cellular morphology after application of BFT. Cells grown on
5% gelatin hydrogels exhibited the loss of E-cadherin junctions after the application of
BFT, supporting the role of BFT as a potential driver of colon carcinogenesis.
The LOC designed and fabricated in this study contained a hollow lumen inside,
formed from a 5% gelatin hydrogel. The lumen shape mimicked the architecture of the
human colon and provided a space for HT29 colorectal cancer cells to adhere to and grow
in. The aim was for cells to form a fully conuent monolayer around the inner lumen
surface. In this study, cells were found to adhere and grow inside the lumen; however, the
initial seeding concentration was too low and the LOC had issues with leakage of media
around the media inlet and outlet. Future work will focus on seeding HT29 cells at an
optimum concentration, calculated in Section 5.5, so that the lumen would be fully coated
within ve to six days of incubation. Work will also aim to optimise the LOC devices
so that they do not leak from around the inlet and outlet channels, possibly through the
use of glue at the tubing-inlet interface, as described in Section 5.5.
90
In this study, the contact angle of three dierent concentration collagen and gelatin
hydrogels were measured to identify hydrophobicity / hydrophilicty of the surfaces. Fu-
ture work will focus on identifying the mechanical properties of the dierent hydrogels
and focus on the optimisation of HT29 adherence and growth on the gelatin hydrogel
surface used in the LOC devices. The morphology of HT29 cells grown on the hydrogels
was also observed in this study to identify whether the hydrogels induced morphologies
which were dierent to those observed on the polystyrene and glass controls, as seen in
Figures 4.1a and 4.14. Future work will focus on integrin-mediated cell adhesion to the
surfaces to identify how the HT29 cells specically bind.
This study showed that BFT obtained from ETBF led to cell rounding and the cleav-
age E-cadherin cell-cell junctions in HT29 cells, which were grown on glass and 5% gelatin
hydrogels (Section 5.6). This work gave proof of concept for the detection and localisation
of the loss of E-cadherin and cell rounding on gelatin hydrogels, as seen in Figures 4.26b
and 4.24b. Future work will focus on optimising and using the LOC device as a more
biologically relevant platform to study carcinogenesis. As mentioned in Section 5.6, BFT
could be applied to HT29 cells inside the lumen by passive pumping, which would mimic
how liquid moves through the human gut. Immunocytochemistry could be also carried
out to localise E-cadherin, nuclei and actin microlaments within the cells grown inside
of the lumens.
Lastly, the LOC devices could be modied to enable the formation of concentration
gradients inside the lumens. Previous studies showed that the addition of an oxygen
channel allowed for the diusion of oxygen into the stream of liquid inside the lumen,
which in turn mixed up the liquid and formed a concentration gradient from one end of
the channel to the other [124]. As technologies for investigation of the mechanisms of
cancer evolve, LOC devices appear to be an attractive options because they enable the
creation of biologically relevant models which may be better than both 2D and 3D cell
culture models. The LOC used in this study has great future potential to model and
investigate carcinogenesis of the human gut, as well as modelling the eects of dierent
toxins and drug treatments on dierent epithelial cancer cell lines.
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